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Abstract
Evaluating Changes in Knowledge, Beliefs, and Behaviors Associated with HPV Following
an Educational Intervention among Women
Crystal Sheaves, MSN, APRN, FNP-BC
.
Background: Prevalence of HPV is estimated to be 10-15% among Americans. HPV is
recognized as the causative agent in 99.7% of all cervical cancers. In 2006, a vaccine was
released to prevent specific types of HPV that cause cervical cancer. Despite demonstrated
vaccine safety and efficacy, vaccine rates are still low at less than 20% among women 18-26
years old. Vaccine uptake may be impacted by women’s HPV knowledge and beliefs.
Aims: The purpose of this study was to evaluate changes in women’s knowledge, beliefs, and
behaviors associated with HPV following an educational intervention study. Specifically, the
study was designed to evaluate the effectiveness of a video-based HPV prevention education
intervention as compared to the standard of care written HPV educational material on improving
women’s knowledge, beliefs, and behaviors regarding HPV prevention.
Methods: This study used a quasi-experimental pre-test/post-test design with delayed
intervention treatment for the control group. Recruitment included women 18-26 years of age
who had not yet had the HPV vaccine.
Results: Both the control and intervention group had low HPV knowledge prior to education.
Knowledge scores increased significantly for both groups following education. Type of
education had no significant impact on HPV knowledge. Women’s willingness to accept the
vaccine for themselves and their children increased for both groups over time, while the women
in the video-based intervention were significantly more willing to accept the vaccine for their
adolescent sons at time 2. Health beliefs related to HPV infection and HPV prevention also

positively changed for both groups over time. Furthermore, health beliefs were a significant
predictor of participants’ willingness to accept the vaccine for themselves at time 2.
Conclusion: Despite the majority of women having regular contact with health care providers
for pap testing in this study, participants had overall low HPV knowledge scores at study
enrollment, which improved following both educational approaches. The women in this study
had an increased willingness to accept the vaccine for themselves and their adolescent children
following education and women receiving the video-based intervention were significantly more
willing to accept the vaccine for their adolescent sons at time 2. Why this happened is unclear,
but perhaps the video-based educational information regarding eligibility for the vaccine was
more gender neutral than the CDC written fact sheet used in this study. Future studies need to
explore why women who have access to regular pap testing are not receiving the HPV
knowledge that would facilitate their ability to make informed decisions regarding HPV primary
prevention. Additionally, future research should investigate the impact of gender neutral
language in HPV educational materials as a means of increasing HPV vaccine uptake among
adolescent males.
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Chapter 1
Human Papillomavirus (HPV) is the most common sexually transmitted infection (STI)
in the United States (US), causing many serious physical and psychological health concerns for
those infected (Weinstock, Berman, & Cates, 2004). Recent advances in HPV screening and
prevention have the potential to positively impact the incidence of disease. However, lack of
HPV knowledge is a barrier to utilization of prevention measures (Bynum Brandt, Friedman,
Annang, & Tanner, 2011; Juraskova , Obrien, et al., 2011). Creative, evidence based, HPV
educational interventions are needed to correct this problem. This study proposes to evaluate the
effectiveness of an innovative and novel video-based HPV educational intervention on
participants' HPV knowledge, beliefs, and behaviors.
Background of the Problem
Pathophysiology
HPV is one of many papillomaviruses found in different animal species (Gearhart, 2011).
Each papillomavirus is species specific, and cross species infection does not occur. Thus only
human papillomavirus is found in the human species (Stanley, 2010). HPV is transmitted
between humans via skin to skin contact (Brandt et al., 2006). Transmission of the virus was not
well understood until the late 20th century. In 1949, HPV genital warts were first recognized as
being contagious and transmitted via a virus, although not until the 1970s did scientists’
hypothesize HPV was associated with cervical cancer (Sarid & Gao, 2011). The first evidence to
support this hypothesis was discovered by Harald zur Hausen in 1983 when HPV types 16 and
18 were identified in association with cervical cancer (Oliveira, 2007; Sarid & Gau, 2011). HPV
is now recognized as the causative agent in 99.7% of all cervical cancers (Ault, 2006). Research
continues to uncover the number of types of HPV and their effect on the human body. To date
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science has identified over 130 subtypes of HPV. Of these 40 are known to infect the genital
tract of humans, 15 of which are known to be oncogenic high-risk types (Stanley, 2010). The
additional 25 types are non-oncogenic low-risk types of HPV, including HPV types 6 and 11
commonly understood to cause genital warts (Stanley, 2010).
HPV is a genome of double stranded DNA, which infects the squamous and glandular
epithelium. Currently there are 8000 base pairs of the genome identified. It is believed the HPV
E6 and E7 oncoprotiens play a major role in cervical cell mutations. These oncoproteins from
high-risk HPV types activate cell oncogenesis, while simultaneously suppressing tumor
suppressor genes found in the host cells (Ault, 2006; Oliveira, 2007). This results in uninhibited
replication of the HPV genes in host cells causing cell dysplasia. These oncogenic HPV types
have been identified as causative organisms in cervical, penile, anorectal, and head and neck
cancers in humans (Sarid & Gao, 2011).
Not all persons infected with HPV will be chronic carriers of the virus or develop
symptoms of the disease. For most infected (90%) with HPV the immune system will clear the
virus from their body within two years of infection (Centers for Disease Control [CDC], 2012;
Ault, 2006). A lack of understanding still exists as to why the immune response is not successful
in clearing the virus from all persons infected. There is evidence that secondary bacterial and
viral infections, viral load, parity, oral contraceptives, and cigarette smoking all play a part in the
lack of immune response in those who go on to develop HPV related symptoms (Ault, 2006;
Villa et al., 2002). Also unknown is the exact incubation period from contraction of HPV to
either clearing of the disease or evidence of symptoms. Originally, HPV was thought to cause
oncogenesis slowly over a period of ten years or more, but recent research suggests oncogenic
changes can occur in as little as three years (Ault, 2006). An important fact is that immune
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clearing of the virus does not appear to confer immunity to HPV. People whose immune system
has cleared a specific HPV type can still be infected with other HPV types, and can even be reinfected with the same HPV type (Villa et al., 2002). For this reason even persons previously
diagnosed with HPV should be encouraged to utilize additional HPV prevention (condoms,
vaccination, and pap screening).
Incidence/prevalence
HPV is recognized as one of the most common STIs worldwide, but precise worldwide
prevalence is difficult to obtain due to differences in access to screening technology and
frequency of screening (World Health Organization [WHO], 2009). The 2009 WHO report
showed that only 5% of women in low-income developing countries have received screening for
HPV, compared to 75% of women in high-income developed countries. Therefore, worldwide
reporting of cervical cancer incidence is the most accurate way to determine probable infection
with high-risk HPV types. Worldwide estimates suggest cervical cancer incidence is 16.2 per
100,000 women (Castellsague et al., 2007), and is the second most common cancer worldwide
(Heymann as cited in Stanhope & Lancaster, 2012). The WHO (2009) reports that the highest
incidence of cervical cancer is seen in the poorest and least developed countries.
In America, HPV is estimated to be the most common STI among adults (Weinstock et
al., 2004). Approximately 26-29 million Americans are infected with HPV, resulting in a
prevalence rate of 10-15% of Americans (Tyring, 1997), consistent with WHO (2007) estimates
of 13.1 % in the United States. The CDC (2009) estimate there will be six million new cases of
HPV each year and at least 50% of people will contract HPV in their lifetime.
Estimates from the National Health and Nutrition Examination Survey (NHANES)
conducted by the CDC examined the prevalence of high-risk and low-risk types of HPV among
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females aged 14-59 years. Overall HPV prevalence was 26.8% (23.3%-30.9%) among females
14-59 years (n=1,921) (Dunne et al., 2007). Prevalence estimates show the total prevalence of
HPV types 6, 11, 16, and 18 to be 18.5%. Findings suggest both high-risk and low-risk types are
more prevalent among 20-24 year old women (55.3% and 36.3% respectively) with overall
prevalence for this age group being 44.8% (95% confidence interval) (Dunne et al., 2007). Both
the 14-19 year olds and the 20-24 year olds had more high-risk than low-risk types of HPV and
higher viral loads than older women. There was a higher prevalence rate of HPV among women
14-24 years (33.8%), compared to older women 25-59 years (25-29 years = 27.4%; 30-39 years
= 27.5%; 40-49 years= 25.2%; 50-59 years = 19.6%) (Dunne et al., 2007).
Extrapolation of exact prevalence estimates of HPV by state are not possible given the
current reporting practices in America (Weinstock et al., 2000). HPV is currently not a
reportable disease in most states. However, inferences can be made based on the incidence of
cervical cancer by state (Horner, Altekruse, Zou, Wilderoff, Katki, & Stinchcomb, 2011). In a
recent CDC report, the incidence of cervical cancer was the highest at 8.5-11.2% among West
Virginia (WV), Kentucky, Maryland, Delaware, New Jersey, Arkansas, Oklahoma, Texas,
Louisiana, Mississippi, Alabama, and Florida (CDC, 2007).
A study sponsored by the CDC and the WV Bureau of Public Health assessed the
prevalence of high-risk HPV (hrHPV) among 814 women in the state using provider collected
and self-collected samples (Reed, et al., 2004). For women younger than 40 years of age the
prevalence of hrHPV types was 25.5%. While women older than 40 years of age had a
prevalence of 12.5% for hrHPV types (Reed, et al., 2004).
These findings of high prevalence rates of hrHPV are consistent with high incidence rates
of cervical cancer found in a study of Appalachian states (Hopenhayn, King, Christian, Huang, &
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Christian, 2008). Out of five Appalachian states, WV was noted to have the highest incidence
rates of cervical cancer (10.9 per 100,000 women) (listed in order of incidence: West Virginia,
Kentucky, Alabama, Pennsylvania, and Ohio). The states with the highest incidence were also
found to be those with the highest levels of poverty and lowest levels of education, factors that
are relevant to WV, an entirely rural Appalachian state (Hopenhayn et al., 2008).
Psychosocial Burden of HPV
Several studies have highlighted the psychological burden of HPV (Bertram &
Magnussen, 2008; Daley et al., 2008; Daley et al., 2010; Kahn et al., 2005; Lagro-Janssen &
Schijf, 2005; McCaffery & Irwig, 2005; Perrin et al., 2006; Sandfort & Pleasant, 2009 ; Waller et
al., 2007). Women diagnosed with HPV have been shown to experience negative emotions of
shame and stigma associated with the diagnosis. These negative emotions are compounded by
the lack of knowledge regarding HPV prevalence among the population. Stigma associated with
HPV has implications for disease prevention in the future. Studies have identified stigma
associated with HPV as a barrier to prevention seeking behaviors, partner notification, and social
support (Friedman & Shepeard, 2007; Perrin et al., 2006). Addressing the psychosocial stigma
attached to HPV diagnosis is important to facilitate successful prevention programs.
The lack of knowledge regarding HPV and cervical cancer screening is associated with
increased feelings of stigma and psychological distress over subsequent positive diagnosis with
HPV (Bertram & Magnussen, 2008; Daley et al., 2008; Daley et al., 2010; Lagro-Janssen &
Schijf, 2005). A study of women's knowledge and experience of stigma associated with
diagnosis of HPV found women's HPV knowledge was low, and that lower knowledge was
associated with higher levels of anxiety and stigma over receiving the diagnosis of HPV
(McCaffery & Irwig, 2005). Regular contact with health care personnel during annual pap
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testing presents an opportunity to increase knowledge and decrease adverse emotional responses
to subsequent diagnosis of the disease (Waller, Marlow, & Wardle, 2009).
Prevention
Primary prevention. Prevention of cervical cancer, a result of infection with HPV,
involves primary prevention through HPV vaccination and secondary prevention through
Papanicolaou (pap) smear screening. Until recently, secondary prevention was the mainstay of
cervical cancer prevention, and was cited as a major factor in the reduction of cervical cancer in
America (Hawkins, Cooper, Saraiya, Gelb, & Polonec, 2011). However, in 2006, the US Federal
Drug Administration (FDA) and the European Union approved the first HPV vaccine for girls
and young women ages 11-26 years (Wheeler, 2007). The first vaccine approved was a
quadrivalent vaccine, marketed as Gardasil®, which provides protection against two oncogenic
types of HPV (types 16 and 18 and two non-oncogenic types of HPV known to cause genital
warts, types 6 and 11). Cervarix®, a bivalent HPV vaccine which protects against oncogenic
types 16 and 18, was approved later that same year (Wheeler, 2007). Most recently the Advisory
Committee on Immunization Practices (ACIP) added the recommendation to vaccinate young
boys ages 11-12 with the quadrivalent HPV vaccine (CDC, August 2011).
Studies show HPV vaccines to be safe and effective at preventing HPV infections, with
both vaccines demonstrating efficacy of 100% for intended HPV types (Wheeler, 2007).
Vaccine side effects appear to be minimal with the most common side effects being pain and
irritation at the injection site (Wheeler, 2007). Because first generation HPV vaccines do not
include all oncogenic types, the possibility for future research to include other HPV types in
vaccine formulations is likely. Additional research is ongoing to determine long-term immunity
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provided by currently approved vaccines, alternate dosing schedules, and the need for and timing
of booster immunizations (Wheeler, 2007).
A problem with prevention has been the low rates of current vaccination. According to
the CDC's National Immunization Survey data (MMWR, February 3, 2012), only 48.7% of
adolescents aged 13-17 years in the US have received ≥ 1 dose of the HPV vaccine, and only
32% have received the recommended ≥ 3 doses of the vaccine series. Rates for WV from the
National Immunization Survey are slightly lower than the national rates at 42.4% of adolescents
receiving ≥ 1 dose of HPV vaccine, and only 25.3% receiving ≥ 3 doses of the vaccine series.
HPV vaccination rates are also low among women 19-26 years old, with only 20.7% of women
having received at least one dose of HPV (MMWR, February 3, 2012). In comparison to other
states, WV ranked in the middle on HPV immunization rates for adolescents with Idaho having
the lowest rates of ≥1 and ≥ 3 HPV doses (28.8% and 17.6% respectively), and Rhode Island
having the highest rates of 73.0% and 55.1% respectively (CDC, December 2011).
Lack of HPV knowledge has been cited as a barrier to immunization (Bynum et al., 2011;
Juraskova, Bari et al., 2011). Several studies have demonstrated support for increasing vaccine
knowledge by addressing health beliefs with educational initiatives as a way of increasing
vaccine intentions (Brewer et al., 2011; Cates, Brewer, Fazekas, Mitchell, & Smith, 2009;
Fazekas, Brewer, & Smith, 2008; Gerend, Cruz, & Shepherd, 2007; Gerend & Magloire, 2008;
Kahn, Rosenthal, Hamann, & Bernstein, 2003; Kahn et al., 2008). A review of HPV vaccine
studies, supports using the Health Belief Model (HBM) to guide future educational endeavors for
HPV vaccine promotion (Mishra, 2011). Included in the model based education are promotional
messages emphasizing efficacy, official's recommendations, and susceptibility to cancer as major
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facilitators of intention to vaccinate. Future HPV vaccine educational efforts should focus on
these facilitators, while eliminating barriers to vaccination.
Secondary Prevention. According to the National Cancer Institute (NCI) 2005 report
78% of sexually active women over the age of 18 years have received a pap test within the past 3
years. This number is relatively high for secondary prevention of HPV related cervical cancer.
Similarly, the CDC (2009) reported a rate of 83.6% for women 18-44 years, 80.6% for women
45-64 years, and 54.9% for women 65 years and older with an average of 73% of women 18
years and older having a pap smear test within the past 3 years.
Pap smear technology has evolved in recent years, relying on thin-prep method of
collection, and utilizing hybrid capture technology to isolate HPV genomes for typing on
abnormal pap smears (Roland, Larkins, Benard, Berkowitz, & Saraiya, 2010). This has led to
fewer false-positive and false-negative pap smear results (Agorastos, Sotiriadis, &
Chatzigeorgiou, 2010).
Pap smear education of women has not kept pace with changes in pap smear technology.
While most women have heard of and have undergone pap smear testing in the US, they do not
fully understand the purpose of pap test screening (Hawkins et al., 2011; Panagopoulou, Giata,
Montgomery, Dinas, & Benos, 2011; Vasconcelos, 2011). In fact, women most often report
other reasons (contraception, pelvic pain or symptoms) for attending clinics for pap smear
testing, not related to HPV or cervical cancer screening (Bayer, Nussbaum, Cabrera, & PazSoldan, 2011; Bertram & Magnussen, 2008; Daley et al. 2010; Friedman & Shepeard, 2007;
Perrin et al., 2006; Vasconcelos, 2011). Contributing to the lack of knowledge, women reported
a lack of education by health care providers during routine pap test visits with 71.6% of them
reporting never receiving information about HPV during the visit. This study highlights the
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need for more HPV and cervical cancer education of women during routine gynecologic pap
visits (Cermak, Cottrell, & Murnan, 2010).
Impact
Despite advances in HPV prevention and screening technology, there remains
underutilization and lack of knowledge regarding preventive services. Those least likely to
access vaccination as a means of prevention (poor, less educated) are the same people at highest
risk of morbidity and mortality associated with HPV. Evidence supports women seeking pap
smear screening have unmet information needs (Daley et al., 2008; Kwan et al., 2010;
McCaffery & Irwig, 2006; Rosen et al., 2010). These unmet educational needs provide evidence
of a major gap in nursing practice that can be addressed through research. This study was
designed to have a direct impact on educational needs of women at high-risk for increased HPV
morbidity and mortality. The aim was to educate in order to change knowledge and beliefs about
HPV, thus promoting behaviors toward increased utilization of HPV prevention (vaccination).
Significance of the Study
Contribution to Nursing Knowledge and Practice
While nursing knowledge has supported a link between lack of HPV knowledge,
increasing HPV stigma, and underutilization of HPV prevention, the best method of delivery of
HPV information has yet to be identified (Bertram & Magnussen, 2008; Carpenter, 2010; Daley
et al., 2010; Kahn et al., 2005, McCaffery & Irwig 2005, Perrin et al., 2006, Sandfort & Pleasant,
2009). Previous research suggests people can be either positively or negatively affected by the
method of delivery and type of HPV information (McCaffery & Irwig, 2005; McCree, Sharpe,
Brandt, & Robertson, 2006). To date, no particular HPV educational program has been shown to
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be most effective in increasing patient knowledge of HPV, decreasing associated stigma, and
changing patient beliefs and behaviors toward HPV prevention.
Understanding which educational interventions are most effective is important to nursing
practice, because nurses have direct access to patients attending primary care clinics, and are
often the first health care providers to provide health specific information for patients. Nurses as
patient educators need access to evidence based effective educational tools. Identification of an
effective educational program, with the potential for wide acceptance by nursing staff as a prepap smear educational tool, is important for nursing practice. Understanding the effectiveness of
such a tool will add to nursing's knowledge and contribute to future interventions by the
profession to decrease the morbidity and mortality associated with HPV.
Potential Impact on Health and Quality of Life
HPV is associated with significant morbidity and mortality. HPV morbidity is related to
the chronic potential recurrence of genital warts, the psychological experience of stigma related
to HPV diagnosis, and fear of cancer associated with HPV related cervical dysplasia. While
HPV mortality has decreased among developed countries utilizing secondary prevention, lives
saved could be greater with increased awareness and acceptance of HPV primary prevention
(vaccination). Currently there is an underutilization of available HPV primary prevention
services. Identification of superior HPV prevention education programs to decrease morbidity
and mortality from HPV is necessary for the continued health and quality of life of our
population.
Social Significance
Socially the video-based HPV educational intervention has the potential for changing
normative views about HPV among the study population. In addition, the evaluation of best
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practice for HPV education delivery could positively impact health care delivery practices.
Improved education regarding HPV has the potential to contribute to decreasing HPV morbidity
and mortality, especially in the rural state of WV where risk factors for HPV and prevalence
rates are relatively high. Therefore, this study sought to provide evidence to support policy
decisions regarding funding to support HPV educational programs that facilitate HPV primary
prevention vaccination, as well as, informing policy decisions to support funding that would
remove the barrier of cost associated with access to vaccination for this age group.
Major Constituents of the Study
Statement of Purpose
The purpose of this research was to evaluate changes in knowledge, beliefs, and
behaviors following an HPV educational intervention among rural women 18-26 years old. It
was hypothesized that video-based first account stories of persons diagnosed with HPV and clear
messages about prevention and treatment measures are more powerful educational tools for
increasing patients’ perceptions of susceptibility and severity of HPV than written information
alone (Rosen et al., 2010; Waller, Marlow, & Wardle, 2007). By increasing perceived
susceptibility and severity of HPV among the study population, there will be increased
knowledge of HPV, decreased HPV stigma, increased perceived benefits to prevention, and
decreased perceived barriers to prevention, resulting in increased intention toward HPV
vaccination uptake.
The decision to use a video-based educational medium along with written material in the
intervention group was made as a way to increase learner engagement in the material. Based on
previous literature, written material alone might not be sufficient to change health beliefs (Rosen
et al., 2010; Waller et al., 2007). Story telling has previously been used in health education of
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patients as a means of increasing the patients’ engagement in the material being presented
(Comas-Diaz, 2012). By augmenting the written information with the addition of video-based
stories the learner will be engaged both visually and auditorily with the information presented in
a way that will increase learning. In addition, the decision to use video-based first account
stories from persons diagnosed with HPV was made on the basis that the information might be
more meaningful when received from persons with similar backgrounds as the patients receiving
the education. This could be construed as using a form of “cultural brokerage” (the use of
culturally competent strategies to reach patients) (Alexander, Uz, Hinton, Williams, & Jones,
2008). In this instance, patients were believed to be more open to hearing about the disease from
women like themselves who have had the disease.
Ultimately, the increased engagement in the educational material was designed to foster
increased perceived susceptibility and severity of HPV among the study population. In addition,
there will be increased knowledge of HPV, decreased HPV stigma, increased perceived benefits
to prevention, and decreased perceived barriers to prevention, resulting in increased HPV
primary prevention (vaccination) utilization behaviors.
Research Question
1. How effective is a video-based HPV prevention education intervention compared to
written HPV educational material at improving women's knowledge, beliefs, and
behaviors regarding HPV prevention?
Hypothesis: The video-based HPV prevention education intervention will be superior to
the written material at improving women’s knowledge, beliefs, and behaviors regarding
HPV prevention.

Sub-questions:
i. How effective is a video-based HPV prevention education intervention
compared to written HPV educational material at improving women’s
knowledge of HPV?
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Hypothesis: The video-based HPV prevention education intervention will
be more effective than the written HPV educational material at improving
women’s knowledge of HPV.
ii. How effective is a video-based HPV prevention education intervention
compared to written HPV educational material at improving health belief
model (HBM) constructs (perceived susceptibility, perceived severity,
perceived benefit, perceived barriers) regarding HPV prevention among
women?
Hypothesis: The video-based HPV prevention education intervention will
be more effective than written HPV educational material at improving
HBM constructs (perceived susceptibility, perceived severity, perceived
benefit, perceived barriers) regarding HPV prevention among women.
iii. How effective is a video-based HPV prevention education intervention
compared to written HPV educational material at improving women’s
behaviors regarding HPV primary prevention?
Hypothesis: The video-based HPV prevention education intervention will
be more effective than written HPV educational material at improving
women’s behaviors regarding HPV primary prevention.
iv. How effective is a video-based HPV prevention education intervention at
decreasing women’s perceived stigma associated with HPV?
Hypothesis: The video-based HPV prevention education intervention will
result in decreased perceived stigma among women in this study.
Definition of Terms
There are four HBM constructs to define in this study; perceived susceptibility, perceived
seriousness, perceived benefit, and perceived barrier. Perceived susceptibility is the likelihood
that participants will understand the prevalence of HPV and will believe themselves to be
susceptible to the disease. Perceived severity is the likelihood that participants will believe HPV
to be personally life threatening if they contract the disease. Perceived benefit is the net positive
effect participants will believe the HPV vaccine will have on protecting them from HPV.
Perceived barriers are any obstacles participants believe will impede their access to the HPV
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vaccine. Additionally, a fifth term, "cue to action", is defined as either an intrinsic or extrinsic
motivator to change participants' health beliefs. In this study, “cue to action” refers to the
educational intervention. However, other “cues to action” are also assessed as part of the study
instrument sub-scale titled cues to action. Lastly, the term HPV behavior is defined as
participants’ intentions toward acceptance of the HPV vaccine at follow-up.
Additional term definitions include, video based HPV prevention education intervention,
defined as video first account stories of persons diagnosed with HPV and factual information
about HPV; written HPV material, defined as a written paper educational handout; HPV
knowledge, defined as awareness or understanding of HPV, that can be gained through personal
experience or association; and perceived stigma, defined as a stereotypical designation based on
a socially undesirable attribute.
Method of Study
The method of study was a quasi-experimental intervention study using pre-test/post-test
design with delayed intervention treatment administered to the control group at study
completion. Women who presented for care at several family planning clinic sites in southern
WV were recruited. The clinics had similar patient demographics, and provided women’s health
care services through the family planning program, WV Breast and Cervical Cancer Screening
program (BCCSP), and private insurance. Patients from half the clinics were assigned to the
control group who received the written HPV educational material only, while the other half of
the clinics were assigned to the intervention group and received the video-based oral educational
intervention and written HPV educational material. Care was taken to avoid spill over between
clinics by separating the control and intervention clinic assignments geographically within the
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region. Additional participants were recruited on line. Online participants were randomized to
either the intervention or control group.
After consent, both groups of women were given pre-tests (instrument is described in
Chapter 3) to assess demographics, HPV knowledge, stigma, health belief model constructs, and
behaviors toward HPV prevention. Following pre-tests, all participants were given a written
HPV educational handout. The intervention participants also watched a short video, which
contained a first account story of a woman diagnosed with HPV. The video also provided a
segment of factual HPV and HPV vaccine information. Information in the DVD was specifically
directed toward changing patient perceptions of the health belief model constructs. All
participants were then encouraged to get the HPV vaccine. Patients requesting the vaccine who
were uninsured or could not afford the vaccine were provided the Merck Patient Assistance
Program Application to seek coverage for the vaccine. At follow-up visits scheduled two month
after the initial assessment, participants in both groups took a post-test measuring the same
variables as the pre-test including a question regarding intention to get the HPV vaccine (but
excluding demographics). Chart audits were conducted at six months post-enrollment in the
study to determine the extent that participants completed the HPV vaccine series.
Theoretical Underpinnings
Rosenstock (1966) described the Health Belief Model (HBM) as a theoretical framework
to understand why people adopted preventive health measures (Figure 1). The model consists of
four constructs (perceived susceptibility, perceived seriousness, perceived benefit, and perceived
barriers) to predict how people will behave toward preventive health care (Carpenter, 2010).
Assumptions of the model are: 1) the stronger people perceived susceptibility and perceived
seriousness of illness, the stronger their behavior toward prevention, 2) the stronger their
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perceived benefit and the weaker their perceived barrier, the stronger their behavior toward
prevention (Carpenter, 2010). Another component of the model is the "cue to action" prompting
people to change their health beliefs. "Cues to action" can be extrinsic (health education
activities) or intrinsic (decreasing health status). To date little is known about which cues to
action are most pertinent to people's health beliefs (Carpenter, 2010). Previous HPV studies
used written educational material as the "cue to action" (Bynum et al., 2011; Gerend &
Shepherd, 2007; Juraskova, Bari et al., 2011; Mishra, 2011). In this study, the "cue to action" is
a video-based first account of persons diagnosed with HPV and cervical cancer survivor stories,
along with factual HPV and HPV vaccine information, designed to change participants perceived
susceptibility, perceived seriousness, perceived benefit, and perceived barriers to prevention. As
written educational handouts alone will be administered to the control group, comparisons can be
made about the most effective "cue to action" regarding HPV prevention following this study.
Strengths of the HBM include the substantial evidence in the literature demonstrating the
model’s use among various populations and disease states (Cummings, Jette, & Rosenstock,
1978). While originally constructed as a way to predict a person’s desire to avoid disease, the
model has also been used to evaluate general health motivations in the absence of disease, and
even beliefs and behaviors associated with the sick-role (Becker & Maiman, 1975).
Additionally, the model has demonstrated reliability in measuring health beliefs (Maiman et al.,
1977), and psychometric validity of Likert and multiple choice techniques for measuring the
model constructs (Cummings et al., 1978). Despite the different ways in which constructs have
been operationalized in study questionnaires the model has remained predictive, which is a
testament to the strength of the model variables (Becker & Maiman, 1975).
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Weaknesses of the model include having greater utility in prospective studies as opposed
to retrospective study designs (Janz & Becker, 1984). In addition, as a psychosocial model the
HBM can only assess an individual’s behavior as the behavior relates to current attitudes and
beliefs. Janz and Becker also point out that the premise of the model is that health is valued by
individuals and there are multiple cues to action. The authors maintain that unless studies take
into account cues to action and other moderator variables, like behaviors that are habitual rather
than cognitive, and economic and environmental barriers to such action, then the model may not
be as good at explaining and predicting behaviors. Additional weaknesses of the model have
been the tendency for studies to operationalize the model constructs in different ways. While the
model has remained predictive despite these variances, developing standardized tools to measure
the model constructs so that comparisons could be made more easily across studies would be
important (Janz & Becker). Lastly, there is a need to assess the model’s predictive value over
time, with the need for additional long-term studies utilizing the HBM (Becker & Maiman,
1975).
Early research of the model suggests the perceived barriers construct is the most
predictive of behaviors, and therefore should receive special attention when operationalizing the
construct. Aspects to consider when operationalizing the construct of perceived barriers are the
social influences and self-efficacy toward behavior change, as both have been shown to be
important components of this construct (Becker & Maiman, 1975; Janz & Becker, 1984). While
the model can be predictive when only one or two models constructs are assessed, the model has
been found to be most predictive when the joint influence of the entire model constructs are
assessed together (Becker & Maiman, 1975).
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Figure 1.
Health Belief Model

Summary
In summary, HPV is the most common STI in the US, and has serious health
consequences for those infected. The morbidity and mortality associated with the disease can be
decreased with increasing utilization of available HPV prevention through vaccination.
Addressing the most effective education ("cues to action") to facilitate HPV prevention uptake
among the population is important to nursing practice. This study evaluated the effectiveness of
a video-based "cue to action" upon participant’s knowledge, beliefs, and intended behavior
toward HPV prevention.
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Chapter 2
This chapter will synthesize the existing literature evaluating changes in knowledge,
beliefs, and behaviors associated with HPV. Any studies addressing HPV knowledge, beliefs,
and behaviors in relation to HPV participant vaccination are included in this review, with special
attention given to those evaluating HPV educational interventions designed to increase
participant vaccination rates. Emphasis is placed on the relevance of findings to future research
designed to change HPV knowledge, beliefs, and behaviors of women. Conclusions were drawn
to inform the design, population choice, and intervention type chosen for the proposed study.
Literature Search Process
A systematic search of health science databases (Academic Search Premier, Women's
Health International, CINAHL, MEDLINE, and PubMED) was performed. Keywords of HPV,
knowledge, beliefs, behaviors, education, information, stigma, shame, prevention and
intervention were used to identify the state of the science in current research surrounding HPV
prevention behaviors. A total of 4,906 articles were found on the initial search. Limits were
then placed for English language, scholarly peer reviewed research studies, interventions aimed
at female participants’ ages 13-64 years old and published since 1999. This year was selected as
a starting point for this search because the most recent Cochrane Review (Shepherd, Frampton,
& Harris, 2011) indicated there were no educational intervention studies reported in the literature
prior to 1999.
After limits were applied, a total of 570 abstracts were reviewed for any studies
evaluating changes in participants’ HPV knowledge, beliefs, or behaviors. Several studies were
found evaluating HPV knowledge, beliefs, and behaviors, but relatively few studies (i.e.
seventeen) included an educational intervention to promote HPV vaccination among women
(Table 1). Because of the paucity of educational intervention studies, the decision was made to
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include any studies discussing HPV knowledge, beliefs, and behaviors in relation to HPV
vaccination (Table 2 & 3). The inclusion of these studies provides additional background for the
proposed study constructs, with the discussion of educational intervention studies illuminating
gaps in the intervention literature that are addressed in the current study (Table 1).
While limits were set for studies of female gender, several recent studies were found to
include men among the female population. Studies containing both men and women were
included in this review if the researchers specified results pertaining to women participants. A
total of 74 studies were synthesized to draw conclusions about HPV knowledge and beliefs, the
educational needs of women, and the types of educational interventions found to be effective at
increasing HPV prevention behavior, specifically vaccination.
Literature Review
Prior to Federal Drug Administration’s release of the HPV vaccine there were relatively
few studies evaluating participants’ HPV knowledge, beliefs, and behaviors. However, since the
introduction of the HPV vaccination, greater emphasis has been placed on studying participants’
knowledge and beliefs surrounding HPV, HPV prevention intentions, and actual HPV prevention
behaviors. This review will describe the research related to knowledge, beliefs, and behaviors
associated with HPV, including a discussion of the educational interventions that have been used
to promote HPV vaccination among women.
Knowledge
Knowledge can be described as the awareness or understanding of something, that can be
gained through personal experience or association (Merriam Webster’s Collegiate Dictionary,
2004). There have been several efforts to measure HPV knowledge in the last twelve years, with
studies utilizing both qualitative and quantitative methods to describe levels of HPV knowledge
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among participants. The most common qualitative methods used have been phenomenology,
content analysis, constant comparative analysis, and framework analysis with both individual
interviews and focus groups. Most qualitative studies have evaluated HPV knowledge among
female participants, who ranged in age between 14-83 years old (Table 2), while a few have
evaluated HPV knowledge among men and women (Bertram & Niederhauser, 2008; Friedman &
Shepeard, 2007; Sandfort & Pleasant, 2009).
Quantitative studies have included descriptive, correlational, experimental, and quasiexperimental designs, and have measured HPV knowledge with a variety of measurement
instruments, many of which were developed by the study authors to meet the purposes of the
particular study. While similar knowledge questions are used in all study instruments, none of
the studies utilized the same instrument more than once among different populations as a way of
increasing instrument psychometric data.
Regardless of study methodology or population addressed, each study invariably
identified deficiencies in HPV knowledge (Table 2 & Table 3). The most frequent knowledge
deficits identified are associated with modes of transmission, prevalence, relationship of HPV to
cancer, and lack of knowledge regarding prevention methods. While some study participants
had heard of HPV, others reported never hearing of HPV. This was true even for participants
who had regular contact with health care providers. For example, many studies showed women
had good attendance for pap screenings, but still had a lack of HPV knowledge (Fry, FerriesRowe, Learman, & Haas, 2010; Kahn et al., 2005; Waller et al., 2009; Warren, 2010).
Continued lack of HPV knowledge among women with regular health care provider contact
appears to be related to a lack of provision of HPV education by health care providers (Bayer et
al., 2011). Despite the deficiencies in HPV knowledge among those having regular contact with

22

health care providers, these participants were more knowledgeable than those not having regular
health care provider access (Mills, Vanderpool, & Crosby, 2011).
Significant consequences have been reported in the literature in relation to participant
lack of HPV knowledge. For instance, lack of HPV knowledge has been identified as negatively
impacting HPV beliefs and intentions toward HPV prevention behaviors. Participants with less
HPV knowledge were reported to be more likely to believe HPV is a stigmatizing illness, related
to promiscuous and morally corrupt behavior by those afflicted (Bertram & Magnussen 2008,
Daley et al. 2008, Daley et al. 2010; Friedman & Shepeard 2007; Perrin et al., 2006). In
connection with this finding, participants who were subsequently diagnosed with HPV
themselves were more likely to experience stigma, shame, and anxiety over the diagnosis (Kahn
et al., 2005; Perrin et al., 2006). Participants were also less likely to report intentions toward
partner notification, and expressed a lack of social support related to internal and external
experiences of stigma when disclosing their diagnosis to family and friends (Perrin et al., 2006).
These negative perceptions of HPV as being a disease that only afflicts those who are sexually
promiscuous can be corrected with increasing knowledge of HPV prevalence among the general
population. Subsequently, understanding the prevalence of HPV can also have a positive impact
upon participants’ knowledge and beliefs toward HPV vaccination as a prevention measure.
Beliefs
Attainment of new health knowledge can inform health beliefs, which are described as
the personal convictions that function to motivate an individual’s health behaviors (Mosby’s
Medical Dictionary, 2008). Health beliefs can be impacted by both internal and external forces
and are likely to change over time as persons are exposed to new concepts regarding health and
illness (Kidwell & Jewell, 2003). Aside from perceived stigma associated with HPV, the most
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commonly measured beliefs in the HPV literature were associated with HBM constructs of
perceived susceptibility, perceived severity, perceived benefits, and perceived barriers.
To date perceived stigma associated with HPV has only been described in the qualitative
literature. HPV stigma beliefs are complex concepts with social and cultural dimensions,
encompassing feelings of shame, guilt, and impropriety in relation to perceived acts of deviant
social behavior (McCaffery & Irwig, 2005). Perceived stigma in the qualitative literature
appears to be associated with a lack of HPV knowledge. Those participants with increased
knowledge of HPV prevalence seemed to describe less perceived stigma associated with HPV,
while those who only associated HPV with sexually transmitted disease information perceived
more stigma associated with the disease (McCaffery & Irwig, 2005).
Other qualitative studies also support this finding, having documented the perception of
stigma associated with HPV among participants with low levels of factual HPV knowledge
(Bertram & Magnussen, 2008; Brown et al., 2007; Daley et al., 2008; Daley et al., 2010; Kahn et
al., 2005; McCree et al., 2006; Perrin et al., 2006). Most found stigmatization was decreased
with increasing knowledge of prevalence of the disease among the general population (Perrin et
al., 2006; Friedman & Shepeard, 2007; Bertram & Magnussen, 2008; Daley et al., 2010). There
was also a strong preference among most study participants to receive HPV information from
health care personnel in a caring atmosphere. This was described as causing less perceived
stigma associated with the disease among study participants (McCaffery & Irwig, 2005; McCree
et al., 2006; Perrin et al., 2006; Brown et al., 2007; Friedman & Shepeard, 2007; Bertram &
Magnussen, 2008).
No quantitative studies have been identified that have yet measured perceived stigma in
association with HPV. Among the quantitative literature, the beliefs most commonly measured
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were associated with the HBM constructs of perceived susceptibility, perceived severity,
perceived benefits, and perceived barriers, with a few studies measuring beliefs associated with
moral norms, social norms, behavior control, and attitudes. These constructs were associated
with the use of other less commonly used theoretical models (Theory of Reasoned Action, Social
Cognitive Theory, Theory of Planned Behavior) (Table 3).
Studies using the HBM have restricted measurement of health beliefs to include only part
of the HBM constructs (Table 3). Many studies only included perceived susceptibility and
severity, which have been described as weaker than perceived benefits and barriers, and weaker
still than the HBM as a whole in predicting changes in prevention behaviors (Carpenter, 2010;
Harrison, Mullen, & Green, 1992). Additionally, researchers have suggested that future HBM
research include moderator variables (like “cues to action”) in addition to the four traditional
model constructs (Carpenter, 2010). Currently, only two HPV studies demonstrated the use of
all four HBM constructs and the moderator variable of “cues to action” (Bynum et al., 2011;
Juraskova, Bari et al., 2011). While Carpenter’s meta-analysis suggest perceived susceptibility
and severity are weaker health belief measures for predicting behavioral outcomes, some HPV
studies utilizing perceived susceptibility and severity found them to be positive predictors of
HPV intentions and behaviors (Table 3).
Behaviors
Behaviors are described as the actions manifested by persons in relation to some type of
stimuli (Merriam-Webster’s Collegiate Dictionary, 2004). Health behavior changes are related
to changes in knowledge and beliefs associated with disease and disease prevention, and are
often reflected in a person’s intentions toward behavior change. However, intentions toward
change alone are not entirely predictive of prevention behavior, therefore, whenever possible a
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recommendation is to evaluate actual behavior rather than intentions toward behavior alone
(Mills et al., 2011). A weakness of many of the studies in this review was the fact that studies
only measured HPV prevention intentions, with few studies actually measuring HPV prevention
behaviors, and those who did assess behaviors did so through participant self-report, rather than
more rigorous methods (chart review) (Table 2 & Table 3).
In general, most of the reviewed HPV research studies supported some relationship
between increasing HPV knowledge and prevention intentions and behaviors (Mills et al., 2011;
Juraskova, Bari et al., 2011; Mock et al., 2007; Patel et al., 2012), however, one study
demonstrated no link between intentions and behaviors following educational intervention
(Juraskova, O'brien et al., 2011). The researchers believed that even though intentions were high
among participants, unidentified barriers to vaccination were possible moderators of actual
vaccine behaviors. Perceiving this to be true, Mills et al. (2011) removed the barrier of vaccine
cost by providing vaccinations for free, and subsequently showed that intentions were related to
behaviors when the barrier of cost was removed. This is contrary to other studies, where no
association was found between cost and behavior (Juraskova, Bari et al., 2011; Patel et al.,
2012). As most studies did not assess perceived barriers, drawing conclusions is difficult
regarding the impact perceived barriers may have on actual HPV prevention behaviors.
In addition, aside from the barrier of cost, concerns over vaccine safety (Juraskova, Bari
et al., 2011) and access to vaccination clinics might present real barriers to actual vaccine
behaviors following education interventions (Mills et al., 2011). Studies also show a connection
between behaviors and moderators of vaccine barriers (Jurasokova, Bari et al., 2011; Mills et al.,
2011; Patel et al., 2012). Examples of moderators of behavior include prevention
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recommendation by health care providers, prevention education interventions, and financial
support for prevention access.
Most studies were among urban populations, with few targeting low-income
disadvantaged rural populations who are disproportionately impacted by HPV and cervical
cancer. The universally low levels of HPV knowledge highlights the need for more intervention
research aimed at increasing women’s knowledge of HPV and HPV vaccination. A gap exists in
the literature for assessing the efficacy of different types of theoretically grounded HPV
educational material on women’s HPV knowledge and prevention intentions.
Theoretical Frameworks Used
There is a lack of theoretical grounding among the HPV literature reviewed. In fact, few
(17out of 69) studies utilized a theoretical framework as part of the study design. Of the
theoretical frameworks utilized, the HBM (10) was the most frequently cited in the HPV
literature (Table 2 & Table 3). Of the studies using the HBM, only four evaluated the
effectiveness of an educational intervention in changing women’s health beliefs toward HPV
prevention (Gerend & Shepherd, 2007; Gottvall, Tyden, Hodlund, & Larsson, 2010; Juraskova,
Bari et al., 2011; Marlow, Waller, & Wardle, 2009). Three of the four evaluated a connection
between changing health beliefs and prevention “intentions”, and one theoretically grounded
study evaluated connections between changing health beliefs and actual HPV prevention
behaviors (Juraskova, Bari et al., 2011).
Educational Interventions as “Cues to Action”
There were a total of twenty-five educational intervention studies to promote HPV
prevention behaviors found in the HPV literature. Among these, three addressed an educational
intervention toward adolescents, with another eleven studies specifically targeting women (Table
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1). Another six studies were found addressing college students, including both men and women
(included in Table 1). Studies specifically directing educational intervention programs toward
women alone included women ages 14 and older, with most studies targeting women 18-26 years
old. Types of educational interventions used were written paper fact sheets or brochures (8),
web delivered fact sheets (4), vaccine information videos (2), DVD of written power point
information (1), face-to-face (5), and face-to-face augmented with written material (5). One of
the face-to-face interventions was indirectly related to increasing women's knowledge by
educating the physicians at the gynecology clinic regarding the importance of educating women
at the time of their annual appointment regarding pap testing. While the educational intervention
was targeted at physicians, the outcome measures of pap smear knowledge were assessed via the
women attending the clinic (Fry et al., 2010). Another face-to-face/media augmented
educational intervention utilized peer lay educators to deliver the content (Mock et al., 2007).
Most educational intervention studies relied on immediate post-test measures as follow-up of
knowledge retention and changes in health beliefs. Only three studies utilized a longer follow-up
period to assess changes in HPV knowledge, beliefs, and behaviors. One of these utilized a one
month follow-up (Doherty & Low, 2008), and two utilized a six-month follow-up (Juraskova,
Bari et al., 2011; Patel et al., 2012).
While the majority of studies showed that educational interventions can increase
prevention intentions (Crosby, Rager, Hanson, & Ribes, 2008; Fry et al., 2010; Juraskova, Bari
et al., 2011; Kahn et al., 2005; Kwan et al., 2010; Mock et al., 2007; Papa, Moore-Simas,
Reynolds, & Melnitsky, 2009), one study showed no change in prevention intentions after
receiving the educational intervention (Patel et al., 2012), and another study showed less
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participant self-intention to get vaccinated, but higher intentions to get the vaccine for their
children following an educational intervention (Ferris, Waller, Owen, & Smith, 2007).
While all studies measuring HPV knowledge showed an increase post-intervention in
knowledge scores, some studies noted knowledge increases were not sufficient following written
educational interventions alone (Rosen et al., 2010; Waller et al., 2007). Few studies have
evaluated the long-term gains in HPV knowledge and beliefs following an educational
intervention, and the subsequent impact on changes in HPV prevention behaviors (Doherty &
Low, 2008; Juraskova, Bari et al., 2011; Patel et al., 2012).
Gaps in the Literature for Future Research
Information from health care providers is cited in the literature as trustworthy and
preferred by women (Bertram & Magnussen, 2008; Brown et al., 2007; Friedman & Shepeard,
2007; McCree et al., 2006; Perrin et al., 2006), and regular contact with health care personnel
during annual pap testing is a good opportunity to increase knowledge and decrease adverse
emotional responses to subsequent diagnosis of HPV (Waller et al. 2009). However, researchers
have shown that women are often not afforded educational information about HPV nor the
purpose of pap testing during routine annual well-woman exams with clinicians (Cermak et al.,
2010; Waller et al., 2009). Reasons for this are complex and might involve clinician lack of
awareness of patient information needs, lack of adequate educational tools, and lack of clinician
time to provide adequate oral review of HPV and pap information. To address these needs, the
current study tested the effectiveness of an educational packet designed for administration during
well-woman exams. The educational packet included both a video delivered oral presentation
and written information. Based on the findings, the educational packet could afford clinicians
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with an effective, time-saving tool to address the educational needs of their female patients who
present for health care visits.
As a result of this review, educational initiatives not based on theoretical principles may
not be as effective at changing health beliefs toward prevention as those with a strong theoretical
basis. In addition, using a strong theoretical framework provides guidance for measurement
outcomes that might be compared across studies in the future. Having uniform, theoretically
grounded intervention tools and outcome measures will contribute to nursing knowledge by
generating research that is suitable for comparative effectiveness studies in the future. Currently,
there are no comparative effectiveness studies evaluating HPV educational interventions across
patient populations.
Only one HPV educational intervention study exists evaluating all HBM constructs to
predict participant health beliefs and behaviors (Juraskova, Bari, et al. 2011). Results of this
study were promising, and included all model constructs in outcome measures. However, the
authors failed to design the actual educational intervention materials around the model
constructs. Therefore, the educational intervention may not have adequately impacted behavior
change outcomes, making it difficult to show a direct cause and effect connection between the
educational intervention offered and the outcomes measured.
To address this lack, the current study proposed to develop a novel educational packet
including video first account stories of persons diagnosed with HPV and written HPV
educational material, which can easily be administered to patients at the time of well-woman
exam visits. The proposed educational packet will be based on theoretical principles of the HBM
intended to positively influence participant health beliefs toward HPV prevention behaviors
(specifically vaccination). Outcome measures of the study will include HPV knowledge, beliefs,
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and behaviors. To assess the effectiveness of the educational packet on behaviors, efforts were
taken to remove barriers that might prevent access to HPV vaccination.
Summary
The literature demonstrates a lack of HPV knowledge and transmission of evidence based
HPV information among the general population. This lack of knowledge has adverse
psychological and physical consequences for those at risk of contracting HPV, as at risk persons
with lower HPV knowledge are less likely to utilize available primary prevention HPV
vaccination services. The proposed educational program will address participant HPV
knowledge and beliefs in an effort to increase participant HPV prevention behaviors.
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Table 1: Educational intervention studies among adult women (number of studies = 17)
Author
Design
Theoretical
Intervention Type
Measures
Underpinnings
None
Face-to-Face lecture
Chang et al.
Quantitative
•
HPV Knowledge
based educational
2013
Quasi•
Vaccine intention
Experimental
seminar

Kester,
Shed-Steele,
DotsonRoberts,
Smith, &
Zimet
2013
Vanderpool
et al.
2013

Krawczyk et
al. 2012

Immediate posttest follow-up
Quantitative

None

Quasi
Experimental
Immediate posttest of
intervention
group
Quantitative
Quasi
Experimental

Quantitative
Experimental

Quantitative

•
•
•

HPV Knowledge
Vaccine Intention
Vaccine History

•
•
•

Low pre-intervention HPV knowledge
Knowledge increased post-intervention
Increased intention toward vaccination post-test

•

62% of the seventy four individuals whose health care provider
mentioned HPV vaccine had received the vaccine, whereas only 3%
initiated vaccination without health care provider recommendation.
Intervention group had higher HPV knowledge scores
38% had already had the HPV vaccine with 19% completion of the
series.
Of those not already having the vaccine, the intervention group was
more likely to have intentions toward vaccination (86%) than the
control group (57%) (OR=2.09;95%CI = 1.02-9.36; p<0.05)
Increased intention for series completion predicted increased behavior
for series completion

•
•
•

Theory of Planned
Behavior (TBP)
and Information
motivation
behavioral skills
model (IMB)
Framework
HBM

Immediate posttest follow-up
Patel et al.
2012

Face-to-Face 10 minute
group education session
for intervention group
only

Findings

TPB

Experimental

13 minute Video
developed based on
IMD Framework to
promote completion of
3 dose series

•
•
•

3 groups:
•
Written HPV
information
•
Video HPV
information
•
Control
Fact Sheet and mailed
Vaccination Reminder
Card to Intervention
Group

•
•

•
•

•
•
•

HPV attitudes
Subjective norms
Perceived behavioral
control
Vaccine intentions
Vaccine behaviors

•

Vaccine Intention
HPV and vaccine
knowledge and awareness

•
•

HPV Knowledge
Vaccine Intentions
Vaccine Behaviors

•
•
•
•
•
•

6 month followup

•
•
•
•
Gerend &
Shepherd.
2011

Quantitative
QuasiExperimental

None

Vaccine Video

•
•
•

HPV Knowledge
Health Beliefs (perceived
barriers)
Vaccine Attitudes

•
•
•

Pre-intervention scores modest and intention to vaccination low
Both written and video group had higher knowledge than control group
at pre and post intervention testing
Both written and video group had increased intentions to vaccinate
post-test than did controls
No difference between type of educational material
Baseline intentions to get vaccinated = 41%
Baseline no intentions to get vaccinated = 31.3%
Reasons for intentions to get vaccinated: worry over CC (65.7%), worry
over genital warts (48.6%), physician recommendation (40%)
Reasons for no intentions to get vaccinated: safety concerns (48.8%),
side effects (48.8%), cost (41.3%), long-term consequences (40.0%),
not being at risk for HPV (28.8%)
HPV knowledge not correlated with vaccine intentions
Intervention was associated with vaccine behavior (5.5% had 1 dose of
vaccine at 6 month follow-up)
Intentions associated with behavior (those with intentions to vaccine
more likely to get vaccinated)
Cost and sexual risk taking not associated with intentions but not
behavior
Low initial HPV knowledge despite most hearing of HPV before
Gain frame or Loss Frame video had no effect on intentions to get
vaccinated
27% had intentions to get vaccinated post-intervention
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Vaccine Intentions

Immediate PostTest and 2 month
Follow-up

•
•
•
•

Juraskova,
Bari et al.
2011

Quantitative

HBM

2 educational fact
sheets

Experimental
Leaflet 1: Cervical
Cancer (CC)
information
Leaflet 2: CC and
Genital Wart (GW)
information

6 Month Followup

•
•
•
•
•
•
•
•

HPV Knowledge
Perceived Severity
Perceived Susceptibility
Perceived Barriers
Perceived Benefits
Cues to Action
Vaccine Intentions
Vaccine Behaviors

(delivered via
computer)

•
•
•
•
•
•
•
•

Juraskova,
O’brien et
al.
2011

Mills et al.
2011

Quantitative
Experimental

TPB and moral
norm constructs

2 month followup

Quantitative

None

2 different Fact Sheets
•
One on HPV,
cervical cancer
•
One on HPV,
cervical cancer,
genital warts
(delivered via
computer)
Brochure
Free Vaccine Voucher

Experimental

•
•
•
•
•
•

Attitudes
Normative Beliefs
Perceived Behavior
Control
Intention
Moral Norms
Behavior

•
•

Sexual Behaviors
Vaccine Behaviors

•
•
•
•

•
•
•
•
•
•
•
•

Stock,

Quantitative

None

Fact Sheet

•

HPV Knowledge

•

30% had no intentions
44% undecided
Perceived barriers to vaccine = safety (26%), cost (17%), fear of shots
(11%), no need (9%), and no access (6%)
Safety and low need were mentioned more often among non-intenders,
other barriers mentioned more often among intenders
↓ HPV Knowledge pre-test [only 55% had heard of HPV, no group
differences in pre-test knowledge (x21=1.12; p<0.05)]
Intentions ↑ post-intervention (n=73, 37% had received the vaccine
post-intervention, and 76% reported sought information with intention
to receive vaccine)
Intentions to get vaccine predictor of behavior to get vaccine postintervention (odds ratio [OR], 2.07; p=0.23; 95% confidence interval
[CI], 1.11-3.89)
Intentions to get vaccine predictor of information seeking behavior
post-intervention
CC+GW group (44%) more likely to get vaccine than CC only group
(32%)
Perceived barriers and Perceived benefits were the greatest predictors of
vaccine intentions (p<0.05)
Barriers = side effect concerns, access, pain, cost, multiple injections
Note: vaccine provided free to this population, but cost was cited as
barrier if they would have to pay for it
Measured Actual Behaviors at 2 month follow up
Intentions, perceived behavior control, and moral norms were predictors
of behavior (could be used to classify 67.1% of cases (x2=12.475;
p=0.029)
Model (TPB) predicted 54% of variance in intention to get vaccination
(R2=0.54 F3,155=61.580, p< 0.001)
Intention predicted 9.6% of variance in behavior (x2=7.355; p=0.007)

Focus was on removing barrier of cost for vaccine to determine
likelihood of vaccination
Clinic participants more likely than college participants to get
vaccinated (measured vaccine behavior through voucher receipts for
shots given)
Clinic population using condoms or oral contraceptive were more likely
to get vaccinated (p=0.0009) and (p=0.010) respectively
College women using IUD were more likely to get vaccinated (p=0.30)
Those having previous pap test more likely to get vaccinated (p=0.005)
Those with no doctor contact in last 12 months less likely to get
vaccination (p=0.036)
Those with hx of abnormal pap were less likely to get vaccination
(p=0.001)
Those participating in mutual masturbation less likely to get vaccination
(p=0.006)
Intervention ↑ knowledge, and perceived risk to HPV [F(1,236)=31.62,
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Peterson,
Houlihan, &
Walsh
2012
Warren
2010

Yanikkerem,
Piyan,
Kavlak, &
Karadeniz
2010
Marlow et
al.
2009

Experimental

Quantitative

•
•
•
•

Oral Sex Willingness
Risk Perception
HPV concern
Vaccine Intentions

Face-to-Face with
written on HPV

•

HPV Knowledge

•
•

None

Face-to-face

•
•

•

•
•

Sexual behavior
HPV knowledge and
awareness
Vaccine Attitudes
Vaccine Intentions

•
•
•

Vaccine Intentions
Vaccine Attitudes
Beliefs (benefits/barriers)

•
•
•

QuasiExperimental

QuasiExperimental

•

None

QuasiExperimental
2 month post-test
Quantitative

•

HBM

Educational fact sheet

•
•

•
•
•
Doherty &
Low
2008

Quantitative

None

Fact Sheet
(delivered via web)

•

HPV Knowledge and
Attitudes

•

Experimental

•
•
•
•
•

Ferris et al.
2007

Quantitative
QuasiExperimental

None

Pamphlet

•
•

HPV Knowledge
Vaccine Attitudes

•

p<.001 (d=0.78; Ms=0.69 vs. 0.49]
Intervention ↓ intention to oral sex among women [F(1,130)=6.47,
p>.02 (d=0.50)]
Men expressed ↑ likelihood to get vaccination after intervention (more
so than women) [F(1,176)=16.85, p<.001 (d=0.71; Ms= 5.49 vs. 4.36)]
↑ knowledge post-intervention
↓ HPV knowledge at pre-test

↓ HPV knowledge pre-intervention (mean pre-test score was 11.6 (SD
1.76, range 10-20)
↑ knowledge post-intervention (mean post-test score was 18.8 (SD 1.52,
range 11-20) (p< 0.001)
↑ positive attitude toward vaccine after intervention (62.4% wanted to
be vaccinated post intervention)
↑perceived susceptibility = ↑ acceptability of vaccine (p<0.001)
↑perceived benefit = ↑ acceptability of vaccine (p<0.001)
↑ barriers (worry about side effects, afraid of needles) = ↓ acceptability
of vaccine (p<0.001)
Benefits and barriers = strongest predictors of acceptability
Culture & religion explained 6% of variance on vaccine acceptability,
but was not significant (F(6,301)=1.43; < the critical value of 2.13 for
p=0.05)
White, higher socioeconomic had ↑ acceptability over ethnically
diverse, lower socioeconomic participants (94% vs. 86% OR=2.38, CI:
1.13-5.05)
Women had higher knowledge (M=5.03, SD=1.77) vs. Men (M=3.75,
SD = 2.23; t(117)=-3.35, p<0.05), women (M=12.74, SD=1.61;
t(117)=-4.02, p<.05) had higher positive attitudes toward vaccine than
men (M=11.45, SD=1.87), women (M=18.31, SD=3.58) had higher
perceived susceptibility to infection on pre-test than men (M= 15.92,
SD=2.78; (t(117)=-4.1,p<0.05)
↑ positive attitudes to vaccine post-test for intervention group
((F(1,116)=3.1, p=0.08)
↑ perceived risk to HPV post-test for intervention group
(F(1,116)=26.1, p<0.001)
↑ knowledge of HPV post-test for intervention group (F1,116)=71.4,
p<0.0001)
Knowledge maintained at 1 month follow-up
Intervention group = clinical improvement, but not significant
improvement on condom use at one month follow-up (N=78)
(intervention group M=61.19% vs. control M=49.64%) on self-report of
condom use post intervention (F(1,15)=0.79, p=0.38)
Attitudes toward getting self- vaccinated ↓ after intervention (59% preintervention vs. 50.2% post-intervention) (when removing neutral
response option from analysis this was not as large and increased to
57% post-intervention)[main reason for not wanting vaccine post-
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•

Immediate PostTest Follow-up

•
•
Gerend et al.
2007

Semi-structured
Interview

HBM

Face-to-Face education

•
•
•
•
•

None

Face-to-face education

•

Correlational

Lambert
2001

QuasiExperimental

Sexual behavior
Vaccine Intentions
Beliefs (benefits/barriers)
Anxiety
Approach-Avoidance
Motivation
HPV Knowledge

•
•

•
•
•
•
•
•

↑ = increased, ↓ = decreased

intervention was report of not being at risk]
Attitudes toward getting daughter vaccinated ↑ after intervention
(65.8% post-intervention, p=0.015, Bowker test of symmetry)
Biggest reason for not wanting vaccine for self was monogamy and low
perceived need (29% and 15% respectively)
Attitudes for those undecided on pre-test were more positive after
intervention
Intentions to get vaccine generally high (mean = 5.40, SD=0.96)
↑intentions correlated with ↑susceptibility, perceived safety, perceived
effectiveness, and physician recommendation, and hx of previous HIV
testing (F[5,45]=14.169, p<0.001)

Lower HPV knowledge pre-test (45% answered correctly pre-test vs.
79% correctly post-test)
PA students’ knowledge > psychology students
Knowledge = between gender
↑HPV knowledge at 3 month follow-up
Physician assistant (PA) students’ knowledge still > psychology
students
Psychology students had > overall improvement in knowledge (32% to
70%) vs. PA students’ knowledge increase (60% to 89%)
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Table 2:
Qualitative HPV knowledge, beliefs, and behaviors studies
Adolescent
Hilton & Smith
2011

United Kingdom

•
•
•
•

N = 87
Female
Ages: 12-18 years
Purposive Sample

Scarinci, BarcesPalacio, &
Partridge

Birmingham &
Anniston Alabama

N = 28 Latina
N = 17 Afr. Amer.

Qualitative

None

Focus Groups
Female

Brief HPV information
provided after initial
discussion of STI
knowledge

2007
Cross-sectional of
Latina Immigrants
and African
American Women
Racktoo &
Coverdale
2009

UK
Female

•
•
•
•
•
•

Qualitative
Focus Groups
Framework Analysis

None

None

•
•
•
•

Age: 12-13 years

•

78 were vaccinated against HPV at time of study
↓ HPV knowledge of transmission
½ knew HPV caused CC
Although most were vaccinated, they didn’t really
understand what the vaccine protected against –
stating mothers made the decision to vaccinate
Only ½ aware of pap test for CC
Lack of knowledge re: STI transmission among
Latina; AA women more knowledgeable
Most had never heard of HPV
After HPV information: AA felt all women at risk,
whereas Latina felt only those with risk factors
presented in presentation
Both groups willing to accept HPV vaccine
Skeptical about vaccine effectiveness, side effects,
cost
Latina had fewer vaccine concerns than AA
↓ HPV knowledge
Barrier = fear of vaccine, pain from shot, concern
over side effects
+ attitude toward acceptance of vaccine despite
vaccine concerns
Preference for education materials (face-to-face or
video augmented by written)

College Students
Sandfort &
Pleasant
2009

Urban

N = 1500
male and female
health professions
college students

•
•
•
•

Quantitative

•

Author
Rosenthal, Dyson,
Pitts, & Garland
2012

Setting
Australia

Population
N = 34

Study Design
Qualitative

Diverse population
from women’s health
and educational
institutions in the
country

Female

Focus Group

Age: 22-77 yo

Women
Theory
None

Intervention
None

•
•
•
•

↑knowledge overall of HPV
↑knowledge = ↓stigma associated with disease
Males = ↑stigma and ↓knowledgeable than females
75% knew HPV was STD, info source TV, friends,
school, internet
Preferred info. source = health care professional
and internet
Findings
Overall knowledge of vaccines assessed with most
being positive toward vaccines in general
More controversy over HPV vaccine in particular
because of negative association with STI
Information needs before getting vaccine included
more info on side effects, effectiveness, and
whether pap test were still needed
In general women said that if information
presented the vaccine was safe, effective and was
doctor recommended they would get the vaccine
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•
•

Francis et al.
2011

Short et al.
2010

South Africa

N = 24

Qualitative

Clinic

Female

Focus Groups

Age: 18-44 years
N= 38

Qualitative

Female

Framework Analysis

University based
gynecologic clinic

None

None

•
•

None

None

•
•
•

Age: 27-55 yo
Mean age 40 yo

•
•
Waller et al.
2009

Nationally
representative of
England, Scotland,
Wales

N = 1081
women 25-64 year

•

Quantitative

•
•
•
•

Daley et al.
2008
2010

Bertram &
Magnussen
2008

Bertram &
Niederhauser

Urban
clinic

Urban

Urban

N = 52 (qualitative
phase) N = 154
(quantitative phase)
women 18-45 years

N = 10
women 18-35 years
with Dx abn. pap in
last 5 years

N = 492, crosssectional, both male

Mixed methods

None

None

•
•
•

Qualitative
Phenomenology

None

None

•
•
•
•

Quantitative

•

and give it to their children
Nurses in the study felt it was important to educate
patient more and noted they often have more time
for this than physicians
Nurses also expressed some lack of information re:
vaccine…needed more info on how long it would
last, should women who are sexually active still get
the vaccine, etc.
↓HPV and CC knowledge
Barriers to vaccine (access, concern over side
effects)

Many had heard of the vaccine, but HPV
knowledge facts were not always accurate
Women felt all women should have access to the
vaccine
Women felt reasons for vaccine were previous
sexual exposure or future exposure if not in a
monogamous relationship
Barrier to vaccine was cost, access, concern over
side effects, negative opinions of others, and lack
of endorsement by physician
Women did not see vaccine status as affecting their
pap smear screening behavior
↓ awareness of HPV prior to study, ↓ knowledge
HPV cancer link
large number reported regular pap screening,
regular screening = less shame/worry than
rare/never screened
Knowledge of HPV as STD = ↑ anticipated shame
General HPV Education on prevalence = ↓shame
Women with college education reported less
shame/worry than those with less formal education
↑HPV knowledge overall, ↓understanding highgrade vs. low grade HPV, transmission, effect on
fertility
Internet common source for info
Dx = stigma, fear, anxiety, self-blame,
powerlessness, anger,
↑knowledge = ↑ power/control over Dx
↑Stigma associated with STD nature of HPV
↓Knowledge of HPV, misinformation,
misunderstanding common
Like internet info for privacy, but too much STD
info, hard to find HPV specific info, prefer health
care provider for info
Female with ↑ risk and those with Hx abn. pap had
↑ knowledge
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2008
Brown et al.
2007

•

and female
Urban

Friedman &
Shepeard
2007

Nationally
representative of US

Waller et al.
2007

Urban

N = 20
women, 25-83 years

N = 314
35 Focus groups
adults age 25-45
years old
N = 909 women

Qualitative

Qualitative

None

None

Face-to-Face
Brief information re:
new HPV pap test as
opposed to old pap test

•

None

•

•
•
•

•
•

Quantitative

•
•
McCaffery & Irwig

Rural

2005

N=44
Women 19-63 years
Dx with High Risk
HPV within the last
year, 68% African
American

•

Qualitative

•
•
•

McCree et al.
2006

South Carolina

N = 50

Qualitative

Clinics

Female

Focus groups

Rural
Predominantly poor
and largely African
American population

Ages: 19-63 years

Constant comparison
analysis

None

None

•
•

•

Purposive sample
(HPV positive)

•
•
•
Perrin et al.
2006

Urban

N = 52
women 18-44 years
recently Dx with
HPV

Qualitative
Content Analysis

None

None

•
•
•

↓knowledge overall, ↓knowledge among male
population
↑stigma associated with sexual transmission of
HPV
+ attitude toward HPV testing
lacked awareness of HPV overall
Education improved resulted in positive attitude
toward HPV testing
↓knowledge overall of HPV, women more
knowledgeable than men
Stigma associated with STD nature of disease
↑stigma and shame in those who knew HPV was a
STD
knowledge of prevalence = ↓stigma, shame, and
anxiety
Written ed. material did not translated into
adequate knowledge of HPV, Need more research
communicating HPV information
Health care provider most trusted source of
information and preferred source overall
Some prefer privacy of written material (brochures
in doctors office), Lack trust/preference for TV,
magazine ads, internet
Prefer easily understandable information, ↓
preference for large amounts to sort through
All expressed need for more HPV/abnormal pap
information overall
Written information felt to be adequate, but some
said brochures contained too much information to
be clearly understood
Video was felt to be a positive means of
information delivery, preferred free video from
trusted source…downside was no ability to interact
with live person
Most preferred method of information delivery was
from health care worker in face-to-face setting
Most felt TV and radio were too commercialized to
be trusted
Access to internet hindered preference for this
media type
***Although all women dx with abnormal pap and
HPV as identified by clinic, only half reported
hearing of HPV
↓ HPV knowledge overall
Dx of HPV = feelings of stigma, powerlessness,
fear, and anger
Disclosure limited due to fear of stigma, when
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75% white, 9.6%
black, 11.5%
hispanic, 3.8% asian
McCaffery et al.
2005

Urban

N = 19
Women

•
Qualitative

•
•
•

•

disclosing emphasized cancer risk rather than STD
association
↑knowledge of prevalence = normalizing = ↓
negative emotions
↓ HPV knowledge overall
Knowledge of prevalence = ↓ stigma, ↓ distress
Follow up only for abnormal results =
↑psychological distress, Prefer routine follow up to
receive pap results, gives opportunity for dialogue
with health care provider, and avoids singling out
HPV + patients
Health care provider best source of information,
internet sources increased confusion and stigma as
HPV info is lumped with other STD's
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Table 3:
Quantitative HPV knowledge, beliefs, and behavior studies
Author
Merzouk et al.
2011

Brabin et al.
2010

Setting
Rural
WV High
Schools
Manchester
England

Population
N = 626
Male & Female
Age: 15-16 yo
Prospective
N= 2817 pre-test
N= 814 post-test
Female

Study Design
Quantitative

ADOLESCENT
Intervention
DVD of power point

Theory
None

Experimental
Quantitative
QuasiExperimental

Elaboration
Likelihood
Model

Film

Age: 12-13 yo
Cross-sectional
Gottvall et al.
2010

Sweden
High school

Wang, Simoni,
& Wu
2006

Author
Bynum et al.
2011

WV High
Schools

Setting
Historically
black colleges

N = 276
Male & Female
Age: 16 yo
Prospective

Quantitative

HBM

Face-to-Face with
Website/Folder
provided

None

QuasiExperimental

N = 159
Female
Ages: 14-20
Purposive
Sample

Quantitative
Survey
Descriptive –
Correlational

Theory of
Reasoned
Action
(TRA)

Population
N = 575

Study Design
Quantitative

Theory
HBM

Male and Female

DescriptiveCorrelational

Florida State
University

Gerend,
Shepherd, &
Shepherd
2011

•
•
•
•
•
•
•
•
•
•

COLLEGE STUDENTS
Intervention
None

•
•
•
•
•
•

N = 739
Female
Ages: 18-26
years

Descriptive Correlational

Southeastern

N = 1612

Quantitative

University

Female

QuasiExperimental

Age: 18-26 yo

•
•
•

•

Ages: 18-26
years
Cross-sectional
Gerend &
Shepherd
2011

•
•

Quantitative

None

None

•
•
•
•

None

Vaccine Video

•
•
•
•

Findings
↑ knowledge of condoms
↑ overall HPV knowledge in intervention group (p > 0.05), but both groups
had good knowledge prior to intervention (82% knew HPV related to CC)
Lack of knowledge re: smoking connection
Intervention ↑ intention to get vaccinated
HPV factual recall assessed 6 months after viewing film was limited (only
34% recalled what film was about, only 60% answered fact questions
correctly, 18% answered incorrectly)
N=29 recalled seriousness of HPV/CC at 6 months
↓ knowledge of condoms for protection
Film ↑ perceived seriousness of HPV (short-term) and ↓ fear of vaccine
Baseline low HPV knowledge for all students,
Intervention ↑ HPV knowledge
Intervention did not change attitudes toward vaccine
Positive attitudes to pap testing and condom use pre- and post-test
Student preference for face-to-face rather than website or folder
↓ HPV knowledge
Sexually active teens more knowledgeable about using condoms to prevent
HPV
Teens in single parent homes more knowledgeable
Findings
75% had heard of HPV (females more than males)
Females more knowledgeable than males
Males scored lower on perceived severity, benefits, cues to action and
higher on perceived barriers than females
No gender difference in perceived susceptibility
71% had heard of the HPV vaccine
Females preferred HPV education from health provider, whereas males
preferred television or internet
Only 3% had not heard of HPV, most knew it was related to CC
↓ knowledge related to genital warts and transient nature of HPV
Mean knowledge scores 4.9 out of 10
Correlates of ↑ knowledge (↑age, sexual activity, non-conservative,
previous STD testing)
Gain frame or Loss Frame video had no effect on intentions to get
vaccinated
27% had intentions to get vaccinated post-intervention, 30% had no
intentions, 44% undecided
Perceived barriers to vaccine = safety (26%), cost (17%), fear of shots
(11%), no need (9%), and no access (6%)
Safety and low need were mentioned more often among non-intenders,
other barriers mentioned more often among intenders
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Stock,
Peterson,
Houlihan, &
Walsh
2012
Vogtmann et al.
2011

College

Mexico
College

Polik & Hardie
2010

Yanikkerem et
al.
2010
Allen et al.
2009

Delaware
Lesbian
Community
groups
Turkey
University
New England
University

Caron, Kispert,
& McGrath
2009

University

Elit, Trim,
Mohan, Nastos,
& Harnish
2009

University

Marlow et al.
2009

United
Kingdom

N = 238
Male & Female
Age: 18-35 yo
Cross-sectional

N = 1109
Male and Female
Age: 17- 26
years
Cross-sectional
Mexican
American
N = 96
Female
Age: > 18 years
Convenience
Sample
N = 553
Male & Female
Age: 18-32 yo
Cross-Sectional
N = 1,401
Female
Ages: > 18 years

N = 361
Female
Age: 18-34 years
Cross-sectional
N = 203
Male and Female
Men = 57
Women = 146
Ages: mean age
19.7 years
Undergraduate
N = 365
Female

College
Age: 16-19 yo
Cross-Sectional

Quantitative

None

Fact Sheet

•
•
•

Intervention ↑ knowledge, and perceived risk to HPV
Intervention ↓ intention to oral sex
Men expressed ↑ likelihood to get vaccination after intervention (more so
than women)

None

None

•

Those more likely to have heard of HPV = older, female, science students,
higher socioeconomic background, having health insurance, and being
sexually experienced
Low HPV knowledge overall

Experimental

Quantitative
Descriptive –
Correlational

Quantitative

•

None

None

•

Descriptive –
Correlational
Quantitative

None

Face-to-face

None

Descriptive correlational

Transtheoret
ical Model,
TRA, Social
Cognitive
theory,
HBM

Quantitative

None

None

Descriptive Correlational
Quantitative

None

None

QuasiExperimental
Quantitative

•

Descriptive

•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•

Quantitative
Quasi
Experimental

HBM

Fact Sheet

•
•
•
•
•
•
•

30% lacked knowledge of HPV transmission among female – female
sexual relations
Openness with health care provider about lesbian status = ↓ knowledge of
HPV transmission
↓ HPV knowledge pre-intervention
↑ knowledge post-intervention (p< 0.05)
↑ positive attitude toward vaccine after intervention
Most had heard of HPV and the vaccine
Those in preparation and action had the highest HPV knowledge scores
Perceived severity highest among those decided against vaccine
Perceived benefits highest among those in preparation and action stages
Those in action stage had lowest perceived barriers
Social norms higher among preparation and action stage participants
All but perceived susceptibility were associated with stage of readiness to
get vaccinated
Most had heard of HPV and the HPV vaccine (85%)
+ attitude to vaccine
↓HPV knowledge (did not differ between men and women)
Internet and family doctor most preferred source of sexual health
information
Women more likely than men to have heard of HPV vaccine
Only 32.6% of women who knew about HPV vaccine expressed interest in
getting vaccine
↓ HPV knowledge pre-intervention
↑perceived susceptibility = ↑ acceptability of vaccine
Barriers to vaccine = worry about side effects, afraid of needles,
↑perceived benefit = ↑ acceptability of vaccine
↑ barriers = ↓ acceptability of vaccine
Benefits and barriers = strongest predictors of acceptability
Culture & religion did not have an effect on vaccine acceptability
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•
Doherty & Low
2008

N = 119

Quantitative

Male & Female

Experimental

None

None

•
•
•
•
•
•
•

None

Face-to-Face

•
•
•
•
•
•

White, higher socioeconomic had ↑ acceptability over ethnically diverse,
lower socioeconomic participants
Women ↑ knowledge, positive attitudes toward vaccine, perceived
susceptibility to infection on pre-test than men
↑ positive attitudes to vaccine post-test
↑ perceived risk to HPV post-test
↑ knowledge of HPV post-test
Knowledge maintained at 1 month follow-up
Intervention group = clinical improvement, but not significant
improvement on condom use at one month follow-up
78% had heard of HPV
Women more knowledgeable than men (94% vs. 62%)
Most had high knowledge scores
Low perceived risk of HPV
64% interested in learning more about HPV
4 women had received HPV vaccine
Of 60 women not previously vaccinated 65% were interested in getting the
vaccine
↓HPV knowledge pre-test
PA students knowledge > psychology students
Knowledge = between gender
↑HPV knowledge at 3 month follow-up
PA students knowledge still > psychology students
Psychology students had > overall improvement in knowledge

•
•
•

Findings
Low pre-intervention HPV knowledge
Knowledge increased post-intervention
Increased intention toward vaccination post-test

None

College

Fact Sheet
(delivered via web)

•
•
•
•
•

Age: N/A
Prospective
Gerend &
Magloire
2008

Florida
University

N = 124

Quantitative

Male and Female

Descriptive –
Correlational

Ages: 18-26
years

Lambert
2001

New York

N = 60

Quantitative

College

Male & Female

QuasiExperimental

Age: > 18 yo
Prospective
Author
Chang et al.
2013

Kester et al.
2013

Setting

Population

Study Design
Quantitative
QuasiExperimental
Immediate posttest follow-up
Quantitative
Quasi
Experimental

Vanderpool et
al.
2013

Immediate posttest of
intervention
group
Quantitative
Quasi
Experimental

Krawczyk et al.
2012

Quantitative
Experimental
Immediate

•

Theory
None

None

TBP and
IMB
Framework

HBM

WOMEN
Intervention
Face-to-Face lecture
based educational
seminar

Face-to-Face 10
minute group
education session for
intervention group
only

•

13 minute Video
developed based on
IMD Framework to
promote completion
of 3 dose series
3 groups:
•
Written HPV
information
•
Video HPV

•

•
•
•

•
•
•

62% of the seventy four individuals whose health care provider mentioned
HPV vaccine had received the vaccine, whereas only 3% initiated
vaccination without health care provider recommendation.
Intervention group had higher HPV knowledge scores
38% had already had the HPV vaccine with 19% completion of the series.
Of those not already having the vaccine, the intervention group was more
likely to have intentions toward vaccination(86%) than the control group
(57%) (OR=2.09;95%CI = 1.02-9.36; p<0.05)
Increased intention for series completion predicted increased behavior for
series completion

Pre-intervention scores modest and intention to vaccination low
Both written and video group had higher knowledge than control group at
pre and post intervention testing
Both written and video group had increased intentions to vaccinate post-
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Patel et al.
2012

University
Clinic

N = 256

post-test
follow-up
Quantitative

Female

Experimental

TPB

information
Control
Fact Sheet

•
•
•
•
•

Age: > 18 yo

•
•
•

Bayer et al.
2011

Peru
Clinics

Bendik et al.
2011

Southeastern
University

N = 185
Female
Age: 18-67 years
Purposive Nonprobabilistic
sample

Quantitative

HBM

None

N = 1,975

Quantitative

None

None

Female

Correlational

•

Age: 18-24

Juraskova, Bari
et al.
2011

•
•
•
•
•
•
•
•
•

Australia

N = 159

Quantitaive

University

Female

Experimental

HBM

2 different Fact
Sheets
Leaflet 1: Cervical
Cancer (CC)
information
Leaflet 2: CC and
Genital Warts (GW)
information

Age: < 26 yo

Juraskova,
O’brien et al.
2011

Australia

N = 159

Quantitative

University

Female

Experimental

TPB and
moral norm
constructs

Mills et al.

Kentucky

Age < 26 yo
N=

Quantitative

None

Fact Sheets
(delivered via
computer)

Brochure

•
•
•
•
•
•
•
•
•
•
•
•
•
•

test than did controls
No difference between type of educational material
Baseline intentions to get vaccinated = 41%
Baseline no intentions to get vaccinated = 31.3%
Reasons for intentions to get vaccinated: worry over CC (65.7%), worry
over genital warts (48.6%), physician recommendation (40%)
Reasons for no intentions to get vaccinated: safety concerns (48.8%), side
effects (48.8%), cost (41.3%), long-term consequences (40.0%), not being
at risk for HPV (28.8%)
HPV knowledge not correlated with vaccine intentions
Intervention was associated with vaccine behavior (5.5% had 1 dose of
vaccine at 6 month follow-up)*** chart review of vaccine uptake
Intentions associated with behavior (those with intentions to vaccine more
likely to get vaccinated)
Cost and sexual risk taking not associated with intentions but not behavior
Only 1 in 5 gave CC information
Few 2.2% gave HPV information
Only 31% gave literature
Only 11.9% gave pap smear information
Amount of Ed. Given influenced by length of visit
Nurses more likely to educate than physicians
↓ HPV knowledge (transmission, prevalence, seriousness)
Perceived importance of HPV, severity of HPV, severity of CC, perceived
likelihood of getting CC, age at sexual debut, # of sexual partners, age,
HPV knowledge were all associated with getting the vaccine
Among unvaccinated students, intentions to get vaccine were influenced by
doctor recommendation to get it (35.4%), being able to pay for it (19.4%),
parents encourage it (16.4%), becoming sexually active (14.0%), having
more sexual partners (9.6%).
↓ HPV Knowledge pre-test
Intentions ↑ post-intervention
Intentions to get vaccine predictor of behavior to get vaccine postintervention
Intentions to get vaccine predictor of information seeking behavior postintervention
CC+GW group (44%) more likely to get vaccine than CC only group
(32%)
Perceived barriers and Perceived benefits = predictors of vaccine intentions
Barriers = side effect concerns, access, pain, cost, multiple injections
Note: vaccine provided free to this population, but cost was cited as barrier
if they would have to pay for it
Measured Actual Behaviors at 2 month follow up
Intentions, perceived behavior control, and moral norms not predictors of
behavior
Model (TPB) predicted 54% of variance in intention to get vaccination
Intention only predicted 9.6% of variance in behavior
Gap between intentions and behavior
Focus was on removing barrier of cost for vaccine to determine likelihood
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2011
Clinic and
College

Female

•

Experimental

Age: 18-26 yo
•
•
•
•

Royer & Falk
2011

4 Urban
Clinics and one
Midwestern
University
classroom

N = 302

Quantitative

Female

Survey data

Ages: 18-24
years
Cross-sectional

Descriptive –
correlational

Common
Sense Model

None

•
•
•
•
•
•
•
•

Teitelman et al.
2011

Wong
2011

Low-Income

N = 34

Mixed-Method

Urban

Female

DescriptiveCorrelational

Malaysia

Ages: 13-26
N = 449

Rural

Female

Quantitative

TPB

None

•
None

None

Fry et al.
2010

Cincinnati

N = 109

Quantitative

Social Service
employees

Female
Ages: 18-65

Descriptive

Urban

N = 383 pre-test
N = 130 post-test

Quantitative

Clinic

Kwan et al.
2010

Hong Kong,
China
Clinic

None

None

None

Face-to-Face
education of
physicians treating
the women

QuasiExperimental
N = 294

Quantitative

Female

Experimental

•
•
•
•

Descriptive Correlational

Convenience
sample
Cermak,
Cottrell, &
Murnan
2010

•
•

None

•

Fact Sheets
Message 1: low
risk(lr)+hight
risk (hr)HPV

•
•
•
•
•
•
•
•
•
•
•
•
•

of vaccination
Clinic participants more likely than college participants to get
vaccinated*** measured vaccine behavior through voucher receipts for
shots given
Clinic population using condoms or oral contraceptive were more likely to
get vaccinated
College women using IUD were more likely to get vaccinated
Those having previous pap test more likely to get vaccinated
Those with no doctor contact in last 12 months less likely to get
vaccination
Those with hx of abnormal pap were less likely to get vaccination
Those participating in mutual masturbation less likely to get vaccination
Most believed HPV would negatively affect their health
Most felt HPV was a chronic illness
Most thought rate of HPV transmission was low
Felt HPV dx would cause them shame and embarrassment, and negatively
impact relationships and willingness to disclose dx
Women likely to believe HPV would result in cancer and or cause outward
symptoms
Women already dx with HPV knew more about it, knew it had fewer
symptoms, and had fewer negative psychosocial beliefs than those not
already dx
53% intended to get vaccine
↑Intentions affected by, younger age of sexual debut, unemployment, +
tobacco use, + hx of STI
Model constructs of attitudes, norms, and behavioral control = predictors
of vaccine intention
↓ HPV knowledge, awareness of vaccine, awareness cervical cancer
screening and CC risk factors
2/3 had intentions to vaccine even though they had never heard of it
↑ knowledge of CC screening and CC risk factors = ↑intentions to vaccine
↓ Intentions to vaccine = fear of safety, embarrassment over getting STI
vaccine, perception of low risk for HPV
Overall need for more education of rural Malaysia women
71.6% reported physician did not educate them on HPV
Only 13.8% reported HPV was discussed by physician
Most do not remember doctor recommending HPV vaccine (76.1%)
Women with higher education had more HPV knowledge than those with
low education
↑ knowledge of difference between pelvic exam and pap test postintervention
No difference in knowledge regarding recommended pap smear interval
↑ Knowledge of what pap smear screens for post-intervention
Spanish speaking women ↑ pap knowledge over English speaking women
↓ HPV knowledge pre-test
↑ intentions to pap smear pre-test
Message 1 = > stigma
Message 2 = Stigma > Message 3, < Message 1

44
•

Age: > 18 yo

•
•
Ilter et al.
2010

Luque et al.
2010

Rosen et al.
2010

Clinic

N = 525

Quantitative

Female

Descriptive

Ages: 19-53
years

Survey

N = 80
Female

Mixed Methods
Survey Design

Central Florida
& Southern
Georgia
Clinics serving
latino migrant
farm workers
Canada

Age: 19-54

Descriptive

Cross-sectional
N = 495

Quantitative

Clinical Trial

Female

Experimental

None

N=

Quantitative

Female

QuasiExperimental

College
Zimet, Weiss,
Rosenthal,
Good, &
Vichnin
2010

Large managed
care database

Age: 18-23 yo
N = 1,375

Quantitative

Female

Descriptive

Ages: 19-26
years
Purposive (those

Message 3 = < stigma
↑ HPV knowledge post-intervention for all groups
↑ post-intervention intentions to pap smear (higher than pre-test)

•
•
•
•
•
•

82% had heard of pap tests, but only 56% had heard of HPV
51% had at least one pap test
Only 52% knew HPV was connected to CC
77% had heard of HPV vaccine
56% reported willingness to get HPV vaccine
Most reported recommendation from health providers as a reason to get
vaccinated

None

•
•

Lack of awareness re: prevention of cervical cancer
Barrier to vaccine was lack of information, cost, fear of safety, access

None

Pamphlets

•

Both forms = ↑ uncertainty and anxiety, but after controlling for inherent
uncertainty/anxiety traits only long form was found to ↑ uncertainty and
anxiety
Authors conclude uncertainty with HPV is inherent and increasing factual
information does not negate it

•

Cross-Sectional

Northeastern
Pennsylvania

•
•
•

None

Age: 30-69 yo

Warren
2010

Message 2:
hrHPV
Message 3:
ds+hrHPV
(ds=destigmatizing
language)
None

None

None

Pamphlet 1=
long form with
more HPV info
•
Pamphlet 2=
short form with
less HPV info
•
Control 1= long
form on general
cancer
prevention
•
Control 2 =
short form on
general cancer
prevention
Face-to-Face with
written

None

•

•
•

↑ knowledge post-intervention
↓ HPV knowledge at pre-test

•

93.5% agreed cervical cancer was a devastating disease and genital warts
are embarrassing 90.0%
73% reported being comfortable talking about sexual health with doctor
of the 185 in this study, 176 reported hearing about the HPV vaccine, but
only 32.4% thought it was important to them
30.1% reported discussing it with their doctor and receiving doctor
recommendation to get the vaccine

•
•
•
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•

not yet
vaccinated
against HPV)

Cates et al.
2009

Dursun,
Altuntas,
Kuscu, &
Ayhan
2009
Papa et al.
2009

North Carolina
Clinic
Rural
Predominantly
black
Turkey

Clinic

Descriptive –
Correlational

N = 1,434

Quantitative

Female

Descriptive

Age: 17-80 years
N = 50

Quantitative

Female

Pitts et al.
2009

Waller et al.
2009

Singapore

England,
Scotland,
Wales

Quantitative

N = 138
Female
Ages: 18-84
years

None

None

•
•
•
•
None

Face-to-Face with
written

Quantitative

Female
Age: 18-49
years
N = 1081

Descriptive –
Correlational
Quantitative

Female

Experimental

None

None

•
•
•

↑ knowledge post-intervention
↓ concern over positive HPV dx post-intervention (those with concern
were related to cancer)
Positive attitude to pap testing with reflex test for HPV

None

•
•
•

↓ awareness of HPV
↓HPV knowledge
+ attitude toward vaccine among those who knew of HPV

Fact Sheet
(delivered via
computer)

•
•
•
•
•
•

↓ low number aware of HPV prior to study
large number reported regular pap screening
lack of knowledge of HPV cancer link
Knowledge of HPV as STD = ↑ anticipated shame
Prior to knowledge of HPV as STD 90% disagreed with anticipated shame
No ↑shame with education on prevalence of HPV or general HPV
education, and women with college education reported less shame/worry
than those with less formal education
Regularly screened pap patients reported less shame/worry than rare/never
screened women
HPV + dx = ↑ intentions to pap test in future
HPV + dx = ↓ smoking intentions in future
HPV + dx = ↑ intentions to get vaccine

QuasiExperimental

Age: > 30 yo
N = 2,145

•
•

Age: 25-64
Nationally
Representative

•
Crosby et al.
2008

Fazekas et al.
2008

Clinic

N = 28

Quantitative

Female

QuasiExperimental

North Carolina

Age: 17-23 yo
N = 146

Quantitative

Clinics

Female

Correlational

Rural

Age: > 18 yo

Precaution
Adoption
Process
Model
Implied Health Belief
Model

While most felt they could obtain the vaccine few actually did, reasons for
not getting vaccinated were marriage, monogamous 54.9%, others thought
it was too new 35.4% or didn't have enough information 31.7%. 24.4%
were concerned about safety and 14.6% were concerned about insurance
covering it
Only 24% of black women had heard of HPV compared to 57% of white
Black women had ↓ knowledge, and were less likely to think HPV was a
serious threat to health, and perceived themselves less likely to get CC
Only 20% of participants had heard of vaccine and did not differ among
race
< half knew of HPV
↓ HPV awareness
+ attitude toward accepting HPV vaccine

Face-to-Face or
Phone

•
•
•

None

•
•
•
•
•
•
•
•

Few knew of HPV, low HPV knowledge
Younger = ↑ intentions toward vaccine
African American = ↓ intentions toward vaccine
Public clinics = ↑ intentions to vaccine over private OB/gyn clinics
Most said HPV vaccine would be most acceptable if it were free
↑perceived likelihood of infection/CC, and ↑ perceived severity of
HPV/CC = ↑intentions
↑ belief in effectiveness = ↑ acceptability of vaccine
Cues to action and ↓ perceived barriers = ↑ acceptability of vaccine
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•
Kahn et al.
2008

Cincinnati

N = 409

Quantitative

Clinic

Female

Correlational

TPB, social
cognitive
theory, HBM

None

•
•
•

Age: 13-26
Sexually
experienced

Ferris et al.
2007

Georgia &
Texas

•

N = 472

Quantitative

Female

QuasiExperimental

Clinic

None

Pamphlet

Mock et al.
2007

North Florida

N= 58

Community
clinics
Santa Clara
County

Female
Age: 18-50
N = 491
(combined
intervention
group)
N = 477 (media
only group)

Community

•
•
•
•

Age: > 25 yo
Gerend et al.
2007

•

Quantitative
Semi-structured
Interview
Correlational
Quantitative

HBM

Face-to-Face

•
•

None

Face-to-Face with
mass media exposure
vs. only mass media
exposure

•
•

None

Written
(delivered via
internet)

•
•
•

None

None

None

None

Experimental

•
•

Women felt daughter more at risk than themselves and therefore more
willing to pay for vaccine for daughters than for themselves
Low vaccine uptake at start of study with only 5% being vaccinated against
HPV with one dose and only 0.2% receiving all 3 doses
66% reported intentions to get vaccinated in next year
68% were dx with HPV with 60% having high-risk types
↓intentions to vaccine = lack of insurance, safety concerns, riskier sexual
activity
↑ intentions to vaccine = ↑ HPV knowledge, belief people in their life
would approve of the vaccine, ↑ perceived severity of HPV, ↑ perceived
benefits to vaccine,
Attitudes toward getting self- vaccinated ↓ after intervention
Attitudes toward getting daughter vaccinated ↑ after intervention
Biggest reason for not wanting vaccine for self was monogamy and low
perceived need
Attitudes for those undecided on pre-test were more positive after
intervention
Intentions to get vaccine generally high
↑intentions correlated with ↑susceptibility, perceived safety, perceived
effectiveness, and physician recommendation, and history of previous HIV
testing
Good pap attendance prior to study
Combined education group sought pap more than mass media group during
study
Both groups had ↑ intentions to get pap as result of intervention
Both groups had ↑ knowledge as result of interventions, but combined
education group scored higher

Female
Age: > 18 yo

Waller et al.
2007

Giles &
Garland
2006
Moreira,
Oliveira,
Neves, Karic,
& Filho
2006

Urban

Prospective
Vietnamese
Americans
N = 811

London

Female

University
Australia

Brazil

Age: college age
N = 90
Female
Age: 18-30
years
N = 204

Clinic

Female

Clinics

Age: 16-23 years

Quantitative
QuasiExperimental
Quantitative
Descriptive
Quantitative
Descriptive

•
•
•
•
•
•

↑ stigma and shame in those who knew HPV was a STD
Knowledge of prevalence = ↓ stigma, shame, and anxiety
Written educational material did not translate into adequate knowledge of
HPV
Need more research on best practices for communicating HPV information
Most had heard of HPV and knew it was an STD
Only 1/3 had heard of HPV vaccine
Lack of knowledge regarding transmission and relation to CC and pap
testing
↓ HPV knowledge
+ HPV vaccine attitudes
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Kahn et al.
2005

Urban

Cross-sectional
N = 100

Clinic

Female

Quantitative

None

QuasiExperimental

Face-to-Face with
visual aids and
written

•
•
•

Age: 14-21 yo

•
•
•

Purposive

•
Kahn et al.
2003

Cincinnati

N = 52

Community &
clinical sites

Female

Quantitative

Age: 18-30 yo
Mean 25 yo

TPB, Social
Cognitive
Theory,
HBM

None

•
•
•
•
•
•
•
•
•

↑ = increased, ↓ = decreased, + = positive

Educational intervention ↑ HPV knowledge
Education and screening = ↑ feelings of empowerment, associated with
doing something positive for their health
↑ HPV knowledge = ↑ self-confidence and locus of control to treatment
and prevention of HPV
+ HPV result = ↑ distress and ↑ anticipated stigma
Educational intervention = ↑ intentions to safe sex practice
Most planned to tell partner of result, those not disclosing tended to be
HPV positive
Reported reason for not disclosing was fear of stigma and feeling
shameful, feared partner anger and rejection, feared perception by partner
that they had been unfaithful
Good knowledge of HPV among study population
+ attitudes about receiving HPV vaccine,75% felt vaccine was safe
62% felt it was very effective
Most had self-perceived risk of contracting HPV
↑perceived severity of HPV/CC
85% with ↑ intention to get vaccinated against HPV
Age, marital status, race/ethnicity, health insurance not associated with
intentions toward vaccination
Knowledge and global belief in goodness of vaccination = ↑ intentions
toward HPV vaccine
Personal beliefs not associated with intentions (susceptibility & severity)
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Chapter 3
This chapter will discuss the research methods and design used for this study. A
discussion of human rights concerns is provided, along with an explanation of the sample
selection criterion and data collection procedures. Parametric and non-parametric analysis
techniques are discussed, and attention is given to the methods used for establishing rigor in this
study.
Design
This study used a quasi-experimental, pre-test and post-test design, with delayed
intervention treatment administered to the control group at study completion. Participants were
recruited both face-to-face and on-line. Participants recruited face-to-face (n = 42, 22%) in this
study were assigned based on clinic location to either the intervention or control group, while
participants recruited on-line (n = 152, 78%) were randomized by the computer program to either
the intervention or control group. A quasi-experimental design was chosen over an experimental
design. The decision to assign face-to-face participants rather than randomize them, as was done
with the online participants, was made due to the potential for participants and staff from the
face-to-face enrollment sites to interact between clinics. Some of the clinics are affiliated with
the same organization and there was concern of spillover with randomization at these sites.
However, because clinics are located in different counties, the decision was made to assign
participants to intervention and control groups based on county. Distance between the county
clinic sites is quite far, thus decreasing the possibility of spillover from one county to another.
Four clinics were identified in two counties (Fayette & Greenbrier) of southern West
Virginia. The clinics are designated Federally Qualified Health Centers (FQHC), with the
mission of caring for rural underserved and uninsured populations. As FQHCs the clinics
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administer similar federally funded programs for cervical cancer screening of women.
Therefore, the participants in both the control and intervention groups who were recruited faceto-face were from similar socioeconomic backgrounds, and utilized similar cervical cancer
screening services at the facilities.
On-line recruitment was initiated after noting that many age eligible women in the clinics
did not meet inclusion criteria for the study due to having received at least one HPV vaccine.
Thus, the protocol was amended to expand recruitment to women in the workforce, general
population, and university school setting. Flyers advertising the study to these women directed
them to an on-line enrollment portal through survey monkey. Women who opted to participate
in the study through this method were randomized to either the intervention or control group.
Human Rights Considerations
The study was approved by West Virginia University’s Internal Review Board (IRB), and
attention was given to the protection of human subjects in compliance with all IRB protocols.
Written and verbal study information (Appendix A) were provided to prospective participants
upon initial recruitment face-to-face, and written informed consent was provided to participants
recruited online. Face-to-face participants were initially informed by clinic staff that a research
study was being conducted, and clinic staff provided the participant with written information
about the study, later referring interested persons to the researcher for verbal information and
written informed consent. Online participants simply clicked a link provided in an information
flyer and were directed to the informed consent for the study. Information sheets detailed the
purpose of the study, the required amount of time for participation in the study, risks and benefits
of participation in the study, the fact that participation was voluntary, and researcher contact
information should participants have further questions about the study.
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The study questionnaire posed no more than minimal risk to participants, and likely
benefitted participants by increasing awareness of HPV and HPV prevention measures.
Additionally, the study intervention DVD and handout posed no more than minimal risk, instead
conferring benefit of increased HPV knowledge, increased positive health beliefs toward HPV
and HPV prevention, and increased willingness to accept the HPV vaccine for themselves and
their adolescent children post-intervention. Because the researcher believed the DVD and
handout intervention would be more beneficial at increasing participants HPV knowledge and
willingness to access prevention services, the researcher provided a delayed treatment protocol
for control group participants, so equal benefit of the study intervention services was provided.
Because the geographic area for this research was rural and included areas where the
researcher was a member of the community, there was the potential for the researcher to be
known personally by some participants in the study. To avoid the potential for coercion, the
researcher avoided direct face-to-face contact with prospective study participants during initial
recruitment. The researcher relied on the clinic staff to distribute the study information sheet and
to notify prospective participants of the availability of a study being conducted at the face-to-face
recruitment sites. Only after reading the information sheet and indicating to the clinic staff their
willingness to participate, were participants referred to meet the researcher for enrollment in the
study. Coercion in the online setting was avoided by having online participants self-selected to
the on-line survey after getting email and bulletin board notification of an available study.
Sample Selection
A prospective cohort sampling design was used in this study, and included women 18-26
years old presenting for health care at the designated clinics and self-selecting to participate
online after receiving notification of the availability of the study. Women were eligible for the
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study if they met the age criteria, were English speaking, were non-pregnant, and had not
received the HPV vaccine prior to study recruitment. This age group was chosen because they
are eligible for the HPV vaccine, and are above the age of consent for vaccination. While
females under 18 years are also eligible for the HPV vaccine, they must have parental consent to
receive the vaccination. Parental consent may not be obtainable in the family planning clinic
setting because many females under 18 years may be presenting for pap testing without parental
knowledge, and confidentiality concerns preclude acquiring parental consent for younger age
groups in this setting.
The selection of 18-26 year olds is significant for this study because many of this age
group in West Virginia are under or uninsured and most do not qualify for traditional free
vaccine programs (like the West Virginia Vaccines for Children (VFC) program). Previous
research has suggested that cost is a major barrier to HPV vaccine uptake (Mills et al., 2011).
However, one study removed the barrier of cost and found that lack of knowledge and concern
for vaccine safety were more significant barriers to vaccine uptake (Juraskova, Bari et al., 2011).
This study will shed additional light on the actual barriers to vaccine uptake and the relationship
of these barriers to knowledge surrounding HPV and HPV prevention among this population.
Women who participated in the study were given a $5 gift card after completing the pretest and received a $10 gift card at the two month follow-up completion of the post-test
questionnaire. The remuneration functioned as an incentive to participate in the study, but could
also address the barrier of cost for transportation to obtain vaccination services. In addition, to
address the barrier of cost for vaccination, the researcher worked with uninsured participants to
access the Merck patient assistance program for free vaccine. Forms for this program were
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provided to those in need and clinic staff assisted uninsured participants wishing to become
vaccinated as a result of participating in the study.
The monetary incentive of $5 and $10 is believed to be sufficient to make participation in
the study worthwhile, but is not excessive given the current price per gallon of gas in the United
States economy. In addition, efforts were made to ensure access to the HPV vaccine for all
participants in the study regardless of health insurance coverage. The attempt to remove the
barrier of cost of the vaccine in this study was necessary to assess the true effects of the study’s
educational intervention effectiveness on vaccination behaviors.
Data Collection
Data collection began upon approval of the study by West Virginia University’s Internal
Review Board (IRB), and continued until adequate numbers were achieved. Initial power
analysis calculations based on a medium effect size, power of 0.80, and level of significance of
0.05, indicates a sample size of 154 would be sufficient for this study if no participants were lost
to follow-up. The initial power calculation used was ten times the number of predictor variables
(4 predictor variables) divided by the percentage of people expected to utilize vaccination in this
study (26%), which is based on the previous percentages in a similar HPV vaccine study (Mills
et al., 2011; Peduzzi, Concato, Kemper, Holford, & Feinstein, 1996). To account for possible
attrition of 20% (attrition number was derived from similar studies’ attrition rates) the decision
was made to oversample, for a total sample size of 193. Recruitment was cut off at 194
participants completing the pre-test and 147 post-test. The decision was made to cut off at this
point after preliminary data analysis suggested the collection to 154 post-test would not have any
significant bearing on the outcome variable.
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Methods to Assure Rigor
To maintain rigor in this study reliability of the study instrument was confirmed.
Reliability refers to the consistency with which an item measures the same construct on two or
more occasions (Polit & Hungler, 1999). Reliability of the instrument measures were
determined by assessing the internal consistency of the tools constructs.
The instrument chosen for this study is based on the HBM and was previously used to
assess HPV knowledge, beliefs, and behaviors among college students (Bynum et al., 2011).
With permission from the instrument author (Appendix E), modifications were made to remove
racial pride constructs from the instrument and to add additional belief construct questions
pertinent to this study. Previous instrument psychometric tests (Table 4) support the tool as an
adequate instrument to measure research questions addressing the effectiveness of HPV
prevention education (Reliability of perceived susceptibility, r=0.42; perceived severity, a=0.80;
perceived benefit, N/A; perceived barriers, a= 0.58; cues to action, a=0.90) (Bynum et al.,
2011). However, the addition of questions to specific belief model constructs (perceived
susceptibility, perceived benefits, and perceived barriers) increased the reliability of these
measures in the current study (Table 5 & 6).
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Table 4. Original Health Belief Model Scales (Bynum, 2011)
Scale

Cronbach
Alpha

Question Set

Perceived Susceptibility

r = 0.42

It is extremely likely that I will get HPV in my
lifetime.
My current behaviors put me at risk for HPV.

Perceived Severity

a = 0.80

HPV is a serious infection.
Cervical Cancer is a serious disease.
Cancer of the Penis is a serious disease.

Perceived Benefits

a = N/A

Getting the HPV vaccine could save my life.

Perceived Barriers

a = 0.58

I couldn’t afford to get the HPV vaccine.
I would not get the HPV vaccine because I am
afraid of needles.
I don’t think vaccines work.

Cues to Action

a = 0.90

Knowing that HPV affects people like me would
encourage me to get the HPV vaccine.
Knowing more about HPV would encourage me to
get the HPV vaccine.
If my doctor recommended that I get the HPV
vaccine then I would.
If my mother approved of the HPV vaccine then I
would approve of it also.
If my grandmother approved of the HPV vaccine
then I would approve of it also.
If my friends approved of the HPV vaccine then I
would approve of it also.

Table 5. Reliability of health belief model constructs
HBM Construct
Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Cues to Action

Original Instrument
r= 0.42
a= 0.80
n/a
a= 0.58
a= 0.90

Modified Instrument
a= 0.75
a= 0.67
a= 0.77
a= 0.80
a= 0.87
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Table 6. Modified Health Belief Model Scales (Current Study n=194)
Scale
Perceived
Stigma

Cronbach
Alpha
a = 0.78

Perceived
a = 0.75
Susceptibility

Question Set
Most people think that people with HPV should be ashamed of
themselves.
Most people think that people with HPV are to blame for their
problem.
Most people think that people with HPV are a danger to others.
Only people who are sexually promiscuous get HPV.
It is extremely likely that I will get HPV in my lifetime.
My current behaviors put me at risk for HPV.
HPV is a very common infection.
My risk of getting HPV is higher than most people’s risk.

Perceived
Severity

a = 0.67

HPV is a serious infection.
Cervical Cancer is a serious disease.
Cancer of the Penis is a serious disease.
HPV can be life-threatening.
HPV is very likely to cause cervical cancer.

Perceived
Benefits

a = 0.77

Getting the HPV vaccine could save my life.
Getting the HPV vaccine could protect me from getting certain
types of HPV.
Getting the HPV vaccine will reduce the chance of me getting
cervical cancer in the future.

Perceived
Barriers

a = 0.80

I couldn’t afford to get the HPV vaccine.
I would not get the HPV vaccine because I am afraid of needles.
I don’t think vaccines work.
I have concerns about whether the HPV vaccine is safe.
I have concerns about whether the HPV vaccine is effective.
I have concerns about possible side effects of the HPV vaccine.

Cues to
Action

a = 0.87

Knowing that HPV affects people like me would encourage me
to get the HPV vaccine.
Knowing more about HPV would encourage me to get the HPV
vaccine.
If my doctor recommended that I get the HPV vaccine then I
would.
If my mother approved of the HPV vaccine then I would approve
of it also.
If my grandmother approved of the HPV vaccine then I would
approve of it also.
If my friends approved of the HPV vaccine then I would approve
of it also.
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The modified instrument is comprised of five-items assessing vaccine acceptability (e.g.
would you get a vaccine to prevent HPV infection? Response options: yes, no, don’t know).
Twelve items assessing HPV knowledge and six-items assessing pap knowledge are assessed
using response options of yes, no, don’t know, and are reverse scored so that correct responses
are given a score of one and incorrect responses and don’t know responses are given a score of
zero. The instrument also includes four-items assessing HPV stigma beliefs, four-items
assessing perceived susceptibility, four-items assessing perceived severity, six-items assessing
perceived barriers, four-items assessing perceived benefits to HPV vaccination, and six-items
assess cues to action toward HPV vaccination uptake. Items assessing health beliefs are scored
on a four-point Likert scale (1= strongly disagree to 4= strongly agree). Other history and
demographic information is assessed to include sexual history, race, age, relationship status, and
education level (Appendix B).
The data collection process began following written informed consent of participants.
After informed consent participants were given the pre-test questionnaire (Appendix B). Then
intervention group participants were given the HPV educational intervention materials to view,
which consist of a short DVD video and HPV fact sheet. The control group received only the
HPV fact sheet (Appendix C). Both groups were encouraged to get the HPV vaccination. Twomonths after registration in the study, all participants received a post-test questionnaire via
mail/email (with stamp addressed return envelope), telephone, or return appointment to the study
site (Appendix D). Six-months after enrollment in the study, chart review was conducted to
assess whether participants completed the HPV vaccine series. At the six-month interval control
group participants were also given the delayed treatment protocol of the DVD and HPV fact
sheet via the mail.
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Data Analysis
Data were analyzed using Statistical Package for the Social Sciences (SPSS) program for
analysis, and data were stored on the researchers password protected computer in a locked office.
Data analysis began with an inspection of the data to identify any outliers or missing data that
could affect analysis results. Once identified, decisions were made on whether to exclude any
outliers or missing data from the final analysis of results. No outliers were identified needing
exclusion from results, but missing data on some questions was noted and analyzed using listwise exclusion.
Data analysis consisted of descriptive statistics of demographic data, such as, age, race,
sexual orientation, relationship status, education level, smoking status, and use of hormonal
contraceptives. Assuming a normal distribution and random sampling, t-test were used to show
differences between the intervention and control groups on HPV knowledge, pap knowledge, and
HPV belief mean scores. Assuming expected category counts of five or greater, Chi-square test
were used to detect group differences on the categorical variables of HPV awareness, HPV
vaccine awareness, HPV prevention behavior, and health information preferences. Assuming
homogeneity of variance, mixed within and between analysis of variance was used to assess the
impact of knowledge and belief scores by group over time. Lastly, logistic regression, using four
predictors (HPV knowledge scores, HPV belief scale scores, group, and insurance) were used to
predict willingness to accept the HPV vaccine.
Summary
A review of the study methodological considerations has been provided with in-depth
discussion of human protection considerations, sample selection, data collection and analysis,
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and steps to assure methodological rigor. Supporting documents are provided to illustrate
materials used in this study (Appendix A, B, C, D).
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CHAPTER 4
This chapter presents results obtained following an educational intervention designed to
change women’s HPV knowledge, beliefs, and behaviors. Data analysis consisted of descriptive
statistics of demographic data, such as, age, race, sexual orientation, relationship status,
education level, smoking status, and use of hormonal contraceptives. Paired samples t-tests were
used to compare pre/post-test measures on HPV knowledge, pap knowledge, and HPV belief
mean scores. Mixed between-within subjects analysis of variance were conducted to show
interactions between type of educational intervention and time on HPV knowledge, pap
knowledge, and HPV belief scale scores. Chi-square tests detect group differences on
categorical variables of HPV awareness, HPV vaccine awareness, HPV prevention behavior, and
health information preferences. Lastly, logistic regression models, using four independent
variables (HPV knowledge scores, HPV belief scale scores, group, and insurance) were
developed to predict prevention behavior.
Results
Sample Description
The mean age of respondents was 22 years of age (SD 2.4, range 18-26). The majority of
respondents classified themselves as white (90%) with the remaining classifying themselves as
black (3%), Hispanic/Latino (2%), Asian (3%), American Indian (0.5%) or other mixed race
(2%). Regarding marital status, 46% were single, 43% were married and/or living with a
partner, and 10% were in a relationship but not living with a partner. Regarding education most
reported having some college or an associate degree (47%), with 23% reporting either high
school graduate or GED equivalent, and 19% reporting a bachelor’s degree, and 6% reporting a
graduate or professional degree (Table 7).
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The study assessed several risk factors related to cervical cancer (Table 8). Several risk
factors were noted among the population. Twenty-one percent of respondents smoked and 56%
reported using hormonal contraceptives, both of which are risk factors associated with cervical
cancer. Additionally, respondents reported early mean age of sexual debut (mean = 17 years,
range 12-26 years, SD 2.4 years), and numerous lifetime sexual partners (mean = 5 partners,
range 1-32 partners, SD 5 partners). Also, increasing their risk of HPV transmission, the
majority reported not using condoms with their last sexual intercourse (57%).
About a third (34%) of the study participants had not yet had pap smear screening tests.
Of the 34% who had not had pap testing, 46% were above the age of 21 years when regular pap
testing is advised. The remaining 54% of women who had not had pap testing were 21 years and
younger, and for these women pap smear screening guidelines require pap testing not start until
women are at least 21 years of age. Among those who had pap smear testing (66%), almost a
third (28%) of respondents reported having an abnormal pap test in the past, which may place
them at high-risk for cervical cancer. Among those with abnormal pap testing (10%), reported
knowing the abnormal results were a result of being diagnosed with HPV.
The sample was also assessed on insurance status. Surprisingly a large number of the
respondents reported having either private insurance or Medicaid (84%). However, they still
reported cost (41%) as the most frequent barrier to getting the HPV vaccine. It was noted that
those who marked cost as a barrier also frequently marked risks of shots (38%) as a barrier to
vaccination. Other barriers to vaccination reported at Time 1 were “not available” (14%),”no
perceived need” (20%), and “other” (21%). The reported barriers decreased slightly at Time 2
with only 33% reporting cost, and risk of vaccines as a barrier at Time 2. The number reporting
non-availability of the vaccine also decreased to 10% and those citing no perceived need dropped
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to 12%, and other 14% for the respondents as a whole (Figure 1). Respondents reported “other”
barriers for not accepting the vaccine as, “meant to do it and just haven’t done it, does not cover
enough strains of HPV, not enough long-term research, at the end of the age bracket so feel it is
not needed now, have already tested positive for HPV, risks of vaccines in general, just don’t
want it, I’m gay so don’t need it, and just don’t want to go to the doctor”.
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Table 7.
Characteristics and demographics of participants (n = 194)
N (%)

Age

194 (100)

Race
White
African American/Black
Hispanic/Latino
Asian
American Indian/Alaskan Native
Other

174(90)
5(3)
4(2)
6(3)
1(.5)
4(2)

Sexual Orientation
Heterosexual
Gay/Lesbian
Bisexual
Unsure

168(88)
4(2)
15(8)
4(2)

Relationship Status
Single
Married
Living with Partner
Divorced/Separated
Other

91(46)
41(21)
43(22)
2(1)
19(10)

Education Level
Less than High School
High School Graduate or GED
Associate Degree or Some College
Bachelors Degree
Graduate/Professional Degree

10(5)
45(23)
91(47)
36(19)
12(6)

Insurance Status
Private Insurance
Medicaid
Clinic Program (Family Planning, Sliding Fee)
Out of Pocket (Private Pay)
None

112(57)
53(27)
8(4)
14(7)
8(4)

Minimum
Maximum

Mean (SD)

18-26

22 (2.4)
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Table 8. Cervical cancer screening & risk factors
N (%)
Sexual Debut (age in years)

173

Minimum
Maximum
12-26

Lifetime Number of Sexual Partners
Smoking Status
Yes
No

157

1-32

42 (21)
155 (79)

Sexually Active
Yes
No

173 (91)
18 (9)

Condom Use with Last Intercourse
Yes
No
Don’t know/not sure

75 (42)
100 (57)
2 (1)

Reason for Condom Use
Prevent Pregnancy
Prevent HIV
Prevent STI
Other

129 (66)
105 (53)
94 (48)
11 (6)

Hormonal Contraceptive Use
Yes
No

111 (56)
86 (44)

Ever Had Pap
Yes
No

128 (66)
65 (34)

History Abnormal Pap
Yes
No
Don’t know/not sure

38 (28)
93 (69)
4 (3)

Diagnosed with HPV
Yes
No
Don’t know/not sure

19 (10)
167 (88)
3 (2)

Diagnosed with Sexually Transmitted Infection
Yes
No

17 (9)
177 (91)

Mean (SD)

5 (4.6)

17 (2.4)
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Figure 2.

Barriers to Vaccine
45%
40%
35%
30%
25%
20%
15%
10%
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Cost
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Shots

Time 1

No Need

Other

Time 2

HPV Awareness and Acceptance of the HPV Vaccine
Overall awareness of HPV and the HPV vaccine were assessed for both the control and
intervention group at time 1 and time 2. Chi-Square test for independence (with Yates
Continuity Correction) showed no significant difference between the control and intervention
groups on awareness of HPV at time 1, x2 (1, n = 193 ) = 0.000, p=0.985, phi = 0.015. While
there was a statistically significant increase in awareness of HPV for both groups following the
educational intervention [control group = x2 (1, n=82) = 13.23, p < 0.001; and intervention group
= x2 (1, n=65) = 6.25, p = 0.012], there was no significant difference between the control and
intervention groups on awareness of HPV at time 2 (with Yates Continuity Correction), x2 (1, n =
147 ) = 1.40, p=0.238, phi = -0.135 (Table 9).
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Table 9.
Heard of HPV
Intervention
Time 1

Time 2

Control

Yes

No

Yes

No

81%

19%

79%

21%

94%

6%

99%

1%

p = 0.012

Sig.
p=0.985

p=0.238

p < 0.001

Nor was there a difference between groups on awareness of the HPV vaccine at time 1 (with
Yates Continuity Correction), x2 (1, n = 188) = 0.115, p=.734, phi = -0.039, or at time 2 (with
Yates Continuity Correction), x2 (1, n = 148) =0 .000, p= 1.00, phi = -0.013. However, there
was a statistically significant increase in awareness of the HPV vaccine for both groups
following the educational intervention [control group = x2 (1, n= 82) = 12.25, p < 0.001; and the
intervention group = x2 (1, n=66) = 13.00, p < 0.001] (Table 10).
Table 10.
Heard of the HPV Vaccine
Intervention
Time 1

Time 2

Control

Yes

No

Yes

No

81%

19%

84%

16%

99%

1%

99%

1%

p < 0.001

Sig.
p=0 .734

p= 1.000

p < 0.001

Respondents were asked about their willingness to accept the HPV vaccine for
themselves and their adolescent children before and after receiving the HPV educational
intervention. There was no difference between the groups on willingness to accept the vaccine
for themselves at time 1 (with Pearson Chi-Square), x2 (2, n=194), = 0.777, p=0.678, phi =
0.063; nor at time 2 (with Pearson Chi-Square), x2 (2, n=146) = 3.89, p=0.143, phi= 0.163.
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Similarly, there was no difference between the groups in willingness to accept the vaccine for
their adolescent daughters at time 1 (with Pearson Chi-Square), x2 (2, n=194) = 4.014, p=0.134,
phi= 0.144, nor at time 2 (with Pearson Chi Square), x2, (2, n=147) = 2.25, p = 0.324, phi=0.124.
Willingness to accept the vaccine for themselves and their adolescent children increased for both
groups over time, and while not significant, the intervention group was slightly more likely to
accept the vaccine for themselves and their adolescent daughters than the control group. Groups
did not significantly differ on willingness to accept the vaccine for their adolescent sons at time
1(with Pearson Chi Square), x2, (2, n=194) = 2.131, p= 0.345, phi = 0.105. However, groups
significantly differed on willingness to accept the vaccine for adolescent sons at time 2 (Pearson
Chi Square), x2, (2, n= 147)= 6.22, p=0.045, phi= 0.206 (Figure 2). Participants in the
intervention group were significantly more likely to accept the vaccine for their adolescent sons
at time 2 than those in the control group.

Figure 3.
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Health Information Preferences
Participants gave information regarding preferences for receiving health information,
sources of health information used most often, and sources of health information trusted most.
Results are presented in Table 11. Overall, participants reported the sources they most preferred
for health information was their health care provider (83%) or the internet (66%), followed by
pamphlets (50%), school health center (35%), television (31%), family (30%), friends (27%) and
other (3%). The sources most used by respondents for seeking health information were health
care provider (72%) or the internet (72%), followed by family (26%), pamphlets (21%), school
health center (20%), television (12%), friends (17%) and other (1%). Despite using other sources
for health information, participants reported the source of health information most trusted was
their health care provider (80%).
Table 11. Health information sources
Preference for
Receiving Health
Information
N (%)
Health Care Provider
163(83)
Pamphlets
98(50)
Internet
120(66)
TV
60(31)
Family
59(30)
Friends
54(27)
School Health Center
68(35)
Other
6(3)

Source Used The
Most

Source Trusted The
Most

N (%)
141(72)
41(21)
141(72)
23(12)
51(26)
33(17)
40(20)
2(1)

N (%)
158(80)
6(3)
16(9)
3(2)
11(6)
4(2)
4(2)
3(2)

Knowledge and Belief Scale Scores
Pap knowledge was assessed with a six-item scale. Percentage of correct responses to the
questions are presented (Table 12) for both time periods. Independent t-test comparing pap
knowledge based on previous pap testing experience is presented in Table 13. Women who had
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not previously had pap testing were significantly less knowledgeable than pap tested women at
both time 1 and time 2.
Paired sample t-test comparing pre/post-test measures (Table 14) showed overall a
statistically significant increase in pap knowledge over time (p = <0.001). Mixed betweenwithin subjects analysis of variance (Table 15) was conducted to assess the impact of the two
educational interventions (written material alone vs. video with written material) on participants
pap knowledge scores, across the two time periods. There was no significant interaction between
the type of educational intervention and time, Wilks Lambda = 0.99, F (1, 140), = 0.718, p =
0.398, partial eta squared = 0.005. The main effect for time was significant, Wilks Lambda =
0.853, F(1, 140), = 24.16, p = <0.001, partial eta squared = 0.147, with both groups showing a
significant increase in pap knowledge scores across time. The main effect for group was not
significant, F (1, 140) = 0.159, p = 0.691, partial eta squared = 0.001, suggesting no difference in
the effectiveness of the two teaching approaches.
HPV knowledge was assessed with a twelve-item scale. Percentage of correct responses
to the questions are presented (Table 16) for both time periods. Paired sample t-test comparing
pre/post-test measures (Table 14) showed overall a statistically significant increase in HPV
knowledge over time (p = <0.001). A mixed between-within subjects analysis of variance was
conducted to assess the impact of the two educational interventions (written material alone vs.
video with written material) on participants HPV knowledge scores, across two time periods
(Table15). There was no significant interaction between the type of educational intervention and
time, Wilks Lambda = 0.99, F (1, 136), = 0.185, p =0.668, partial eta squared = 0.001. The main
effect for time was significant, Wilks Lambda = 0.838, F (1, 136), = 26.27, p = <0.001, partial
eta squared = 0.162, with both groups showing a significant increase in HPV knowledge scores
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across time. The main effect for group was not significant, F (1, 136) = 0.344, p =0 .558, partial
eta squared = 0.003, suggesting no difference in the effectiveness of the two teaching
approaches.
Table 12. Descriptive Statistics
Pap smear knowledge questions

A pap smear is a test to find out if a woman is pregnant

N (%) Correct
Time 1 Time 2
162 (85) 129(88)

All women should be getting pap smears by the time they are 21 years old

150(79)

130(88)

85(45)

68(46)

161(84)

145(98)

141(74)

132(91)

139(73)

114(77)

A pap smear checks for changes in the cells of a woman’s uterus, also
called the womb
A pap smear checks for changes in the cells of a woman’s cervix
Getting regular pap smears is the best thing a woman can do to prevent
cervical cancer
If a woman has a pap smear result that is not normal that usually means
that she has cancer
Table 13. T-test
Comparing pap knowledge based on previous exposure to pap testing
Pap Knowledge
Pap Testing
Mean
SD
t
df
Score
No
3.31
2.09
Time 1
Yes
4.91
1.16
-5.451
73.65
No
Yes

Time 2

4.50
5.16

1.17
.814

-3.689

Table 14. Paired Sample T-Test
Knowledge and belief scale scores over time
N
Minimum
Mean
Maximum
142
0
4.28 (Time 1)
Pap
6
4.85 (Time 2)
Knowledge

89.41

Sig. (2-tailed)

<0.001

<0.001

SD

Sig.

1.72
1.08

<0.001

HPV
Knowledge

138

0
12

7.28 (Time 1)
8.52 (Time 2)

3.37
2.43

<0.001

Belief Scale
Scores

116

0
81

47.95 (Time 1)
49.66 (Time 2)

8.03
7.72

0.007
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Table 15. Mixed Within and Between Analysis of Variance
Impact of educational intervention
Control
Intervention
N
M
SD
N
M
SD
Pap
78
4.29
1.81 64 4.28
1.61
Pre-Test
Knowledge
78
4.76
1.12 64 4.95
1.03
Post Test
HPV
Knowledge

Belief Scale
Scores

Pre-Test
Post Test

78
78

7.44
8.59

3.46
2.37

60
60

7.08
8.43

3.27
2.53

Pre-Test
Post Test

60
60

47.68
49.63

8.74
8.67

56
56

48.25
49.69

7.26
6.64

Wilkes Lambda
0.99,
F(1,140)=0.718,
p=0.398, partial eta
squared = 0.005
0.99,
F(1,136)=0.185,
p=0.668, partial eta
squared = 0.001
0.99, F(1,114)=
.163, p=0.687,
partial eta squared =
0.001

Table 16.
HPV knowledge questions

HPV can cause HIV/Aids
You can always tell when someone has HPV
HPV can cause abnormal pap smears/Pap test
Only women get HPV
HPV can cause herpes
HPV can cause genital warts
You can have HPV without knowing it
HPV is a sexually transmitted infection (STI) or STD
HPV can cause cervical cancer
The HPV vaccine protects against all HPV infections
Condoms are not 100% effective at preventing HPV
HPV is spread by skin to skin contact

N (%) Correct
Time 1
Time 2
108(57)
81(55)
151(80) 122(84)
149(79) 128(88)
116(61) 106(73)
79(42)
67(46)
79(42)
90(63)
156(83) 137(94)
134(71) 116(80)
150(79) 132(90)
74(39)
75(52)
139(74) 121(82)
61(32)
70(48)

HPV related health beliefs were assessed using belief subscale scores that were compiled
for a total belief scale score. The subscales consisted of perceived stigma, perceived
susceptibility, perceived severity, perceived barriers, perceived benefits, and cues to action.
Paired samples t-test comparing pre/post-test measures showed overall a significant increase in
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total Health Belief Scale Scores over time (Table 14). Additionally there was a significant
increase in participant severity subscale scores over time (p = 0.001), and benefits subscale
scores did not change significantly over time (p = 0.072). There was no significant change in
any of the other subscale scores over time, but there was a trend in the sample toward lower HPV
related stigma beliefs, higher severity, susceptibility, and benefits beliefs, lower barriers beliefs,
and increased beliefs in cues to action at time 2 (Table 17).

Table 17. Paired Sample T-Test
Belief sub-scale scores over time
N

Mean

SD

Sig.

Stigma Scale
Scores

139

5.16 (Time 1)
4.94 (Time 2)

2.43
2.13

0.259

Susceptibility
Scale Scores

135

4.71 (Time 1)
4.8 (Time 2)

2.30
2.22

0.595

Severity
Scale Scores

138

9.01 (Time 1)
9.49 (Time 2)

1.69
1.59

0.001

Barriers
Scale Scores

136

7.73 (Time 1)
7.45 (Time 2)

3.65
3.27

0.204

Benefits
Scale Scores

142

6.09 (Time 1)
6.30 (Time 2)

1.51
1.29

0.072

Cues to
Action Scale
Scores

137

10.73 (Time 1)
11.17 (Time 2)

3.67
8.03

0.158
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Mixed between-within subjects analysis of variance was conducted on each subscale and
the total belief scale scores to assess the impact of the two educational interventions (written
material alone vs. video with written material) on participants’ scores, across two time periods.
There was no difference between the groups detected. The subscale results and interpretations
are presented in (Table 18) and the subscale responses are presented in Table 19.
In relation to the subscale of perceived stigma associated with HPV there was no
significant interaction between the type of educational intervention and time, Wilks Lambda =
0.99, F (1, 137), =0 .890, p =0.347, partial eta squared = 0.006. The main effect for time was
also not significant, Wilks Lambda =0.99, F (1, 137), = 1.051, p = 0.307, partial eta squared =
0.008, with neither group showing a significant decrease in HPV related stigma beliefs across
time. The main effect for group was also not significant, F (1, 137) = 0.005, p = 0.942, partial
eta squared =0.000, suggesting no difference in the effectiveness of the two teaching approaches
on HPV related stigma beliefs.
The subscale of perceived severity of HPV showed no significant interaction between the
type of educational intervention and time, Wilks Lambda = 0.99, F (1, 136), = 0.188, p = 0.665,
partial eta squared = 0.001. However, the main effect for time was significant, Wilks Lambda =
0.99, F (1, 136), = 10.72, p = 0.001, partial eta squared = 0.073, with both groups perceiving
greater severity of HPV across time. The main effect for group was not significant, F (1, 136) =
0.884, p = 0.349, partial eta squared =0 .0060, suggesting no difference in the effectiveness of
the two teaching approaches on changing participants perceived severity of HPV beliefs.
The subscale of perceived benefits to HPV vaccination showed no significant interaction
between the type of educational intervention and time, Wilks Lambda = 0.99, F (1, 140), =
0.204, p = 0.652, partial eta squared = 0.001. The main effect for time was also not significant,
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Wilks Lambda = 0.97, F (1, 140), = 3.112, p = 0.08, partial eta squared = 0.022, with neither
group showing a significant increase in perceived benefits to HPV vaccination across time. The
main effect for group was also not significant, F (1, 140) = 0.274, p = 0.602, partial eta squared =
0.002, suggesting no difference in the effectiveness of the two teaching approaches on perceived
benefits of HPV vaccination.
Cues to action were also assessed and showed no significant interaction between the type
of educational intervention and time, Wilks Lambda = 0.99, F (1, 135), = 0.176, p = 0.676,
partial eta squared = 0.001. The main effect for time was also not significant, Wilks Lambda =
0.98, F (1, 135), = 2.098, p = 0.150, partial eta squared = 0.015, with neither group showing a
significant increase in cues to action scores across time. The main effect for group was also not
significant, F (1, 135) = 1.358, p = 0.246, partial eta squared = 0.010, suggesting no difference in
the effectiveness of the two teaching approaches on cues to action scores. (Note: The cues to
action sub-scale assessed in the study instrument were separate from the overall study “cue to
action”, which was the educational intervention).
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Table 18: Mixed Within and Between Analysis of Variance
Impact of educational intervention by belief subscales
Control
Intervention
N
M
SD N
M
SD

Wilkes Lambda

Stigma Scale
Scores

Pre-Test
Post Test

77
77

5.25
4.87

2.62
2.20

62
62

5.04
5.03

2.20
2.05

0.99, F (1, 137)=0.890,
p=0.347, partial eta
squared = 0.006

Susceptibility
Scale Scores

Pre-Test
Post Test

73
73

4.69
4.95

2.47
2.44

62
62

4.74
4.64

2.09
1.94

0.99, F (1,133)= 0.968,
p=0.327, partial eta
squared =0.007

Severity Scale
Scores

Pre-Test
Post Test

74
74

9.14
9.56

1.65
1.61

64
64

8.85
9.40

1.73
1.59

0.99, F (1,136)= 0.188,
p=0.665, partial eta
squared = 0.001

Barriers Scale
Scores

Pre-Test
Post Test

72
72

7.59
7.27

3.89
3.80

64
64

7.89
7.65

3.38
2.57

0.99, F (1,134)= 1.00,
p=0.847, partial eta
squared = 0.000

Benefits Scale
Scores

Pre-Test
Post Test

77
77

6.11
6.37

1.63
1.30

65
65

6.06
6.21

1.37
1.29

0.99, F (1,140)= 0.204,
p= 0.652, partial eta
squared = 0.001

Cues to Action
Scale Scores

Pre-Test
Post Test

75
75

10.50 3.96
10.82 3.57

62
62

11.01 3.30
11.59 3.78

0.99, F (1,135)= 0.176,
p= 0.676, partial eta
squared = 0.001
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Table 19.
Belief subscale responses
Stigma Beliefs

N (%)

Mean
Score
Most people think that people with HPV should be ashamed of themselves
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
31(17)
94(50
53(28)
9(5)
1.7817
Post-Test
30(21)
75(52) 36(25)
4(3)
1.0986

t
value

Sig. (2
tailed)

6.476

< 0.001

Most people think that people with HPV are to blame for their problem
Strongly Disagree Agree Strongly
Agree
Disagree
Pre-Test
26(14)
75(40) 76(40)
11(6)
1.5793
Post-Test
23(16)
64(44) 53(36)
7(5)
1.7034 -1.587

0.115

Most people think that people with HPV are a danger to others
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
20(11)
57(31) 94(51)
14(8)
1.4085
10(7)
1.5423 -1.785
Post-Test
17(12)
56(38) 64(44)

0.076

Only people who are sexually promiscuous get HPV
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
57(30)
88(47) 38(20)
5(3)
2.0552
13(9)
1.9517
Post-Test
39(27)
75(50) 21(14)

0.079

1.768
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Table 19 (cont).
Belief subscale responses
Susceptibility Beliefs

N (%)

t
value

Sig. (2
tailed)

It is extremely likely that I will get HPV in my lifetime
Strongly Disagree Agree
Disagree
Pre-Test
38(20)
96(52)
43(23)
Post-Test
35(24)
57(39)
43(30)

Strongly
Agree
9(5)
1.0845
10(7)
1.1972 -1.562

0.121

My current behaviors put me at risk for HPV
Strongly Disagree
Disagree
Pre-Test
76(41)
66(36)
Post-Test
62(42)
58(40)

Strongly
Agree
5(3)
2(1)

1.593

0.113

HPV is a very common infection
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
1(.5)
57(31) 107(58) 21(11) 1.8392
Post-Test
0(0)
29(20)
97(67)
19(13) 1.9371 -1.961

0.052

My risk of getting HPV is higher than most people’s risk
Strongly Disagree Agree
Disagree
Pre-Test
64(34)
91(49)
28(15)
Post-Test
41(29)
85(60)
14(10)

0.819

Agree
39(21)
25(17)

Mean
Score

Strongly
Agree
3(2)
2(1)

.8881
.7762

.8571
.8429

.229
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Table 19 (cont).
Belief subscale responses
Severity Beliefs

N (%)

Mean
Score

t
value

Sig. (2
tailed)

Strongly Disagree Agree Strongly
Disagree
Agree
2(1)
21(11) 116(63) 46(25) 2.2028
1(.7)
8(6)
80(55)
57(39) 2.3357 -2.322

0.022

HPV is a serious infection

Pre-Test
Post-Test

Cervical cancer is a serious disease
Strongly Disagree
Disagree
Pre-Test
0(0)
5(3)
Post-Test
0(0)
0(0)

Agree

Strongly
Agree
118(63) 2.6207
100(68) 2.6828 -1.263

0.209

HPV can be life-threatening
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
2(1)
23(12) 110(60) 50(27) 2.1250
Post-Test
0(0)
11(8)
79(54)
57(39) 2.3125 -3.264

0.001

HPV is very likely to cause cervical cancer
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
0(0)
24(13) 124(67) 36(20) 2.0857
Post-Test
0(0)
16(11)
92(64)
36(25) 2.1500 -1.194

0.235

63(34)
47(32)
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Table 19 (cont).
Belief subscale responses
Barrier Beliefs

N (%)

I cannot afford to get the HPV vaccine
Strongly Disagree
Disagree
Pre-Test
47(26)
65(35)
Post-Test
41(28)
66(45)

Agree
56(30)
33(23)

Mean
Score

t
value

Sig. (2
tailed)

Strongly
Agree
16(9)
1.8511
6(4)
1.9574 -1.617

0.108

I would not get the HPV vaccine because I am afraid of needles
Strongly Disagree Agree Strongly
Agree
Disagree
Pre-Test
81(44)
56(30)
32(17)
17(9)
2.1736
Post-Test
66(45)
53(36)
20(14)
8(5)
2.2222

-.725

0.470

27(15)
8(6)

Strongly
Agree
13(7)
2.1831
3(2)
2.2887 -1.699

0.092

I have concerns about whether the HPV vaccine is safe.
Strongly Disagree Agree
Disagree
Pre-Test
22(12)
56(30)
73(40)
Post-Test
18(12)
49(33)
60(41)

Strongly
Agree
33(18) 1.3776
20(14) 1.4406 -1.069

0.287

I do not think vaccines work.
Strongly Disagree
Disagree
Pre-Test
70(38)
75(41)
Post-Test
55(38)
79(55)

Agree

I have concerns about whether the HPV vaccine is effective.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
19(10)
68(37)
81(44)
18(10)
Post-Test
14(10)
51(35)
64(44)
18(12)
I have concerns about possible side effects of the HPV vaccine.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
14(8)
57(31)
85(46)
31(17)
Post-Test
16(11)
37(25)
70(48)
23(16)

1.4931
1.4028

1.529

0.129

1.2917
1.3056

-.226

0.822
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Table 19 (cont).
Belief subscale responses
Benefits Beliefs

N (%)

Mean
Score

t
value

Sig. (2
tailed)

Getting the HPV vaccine could save my life.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
8(4)
32(17) 120(65) 26(14) 1.8897
Post-Test
1(.7)
21(14) 100(68) 25(17) 2.0069 -2.205

0.029

Getting the HPV vaccine could protect me from getting certain types of HPV.
Strongly Disagree Agree Strongly
Agree
Disagree
Pre-Test
0(0)
13(7)
130(70) 44(24) 2.1818
Post-Test
1(.5)
4(2)
112(77) 28(19) 2.1469

0.468

.728

Getting the HPV vaccine will reduce the chance of me getting cervical cancer in the future.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
1(.5)
28(15) 125(68) 31(17) 2.0350
Post-Test
1(.7)
10(7)
100(68) 36(25) 2.1538 -2.135 0.035
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Table 19 (cont).
Belief subscale responses
Cues to Action

N (%)

Mean
t
Sig. (2
Score value tailed)
Knowing that HPV affects people like me would encourage me to get the HPV vaccine.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
4(2)
36(20) 116(63) 29(16) 1.9241
Post-Test
2(1)
26(18)
93(63)
26(18) 1.9655 -.687
0.493
Knowing more about HPV would encourage me to get the HPV vaccine.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
6(3)
25(14) 112(61) 42(23) 2.0140
Post-Test
7(5)
21(14)
90(61)
29(20) 1.9720

.581

0.562

If my doctor recommended that I get the HPV vaccine then I would get it.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
4(2)
50(27)
91(49)
41(22) 1.9021
Post-Test
6(4)
35(24)
69(48)
35(24) 1.9091

-.111

0.912

If my mother approved of the HPV vaccine then I would approve of it also.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
13(7)
55(30)
88(47)
30(16) 1.7273
Post-Test
10(7)
40(27)
68(47)
28(19) 1.7692

-.638

0.524

If my grandmother approved of the HPV vaccine then I would approve of it also.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
16(9)
68(36)
77(41)
26(14) 1.6224
Post-Test
7(5)
45(31)
71(49)
22(15) 1.7343 -1.577
If my friends approved of the HPV vaccine then I would approve of it also.
Strongly Disagree Agree Strongly
Disagree
Agree
Pre-Test
19(10)
73(39)
70(37)
25(13) 1.5764
Post-Test
10(7)
49(34)
62(43)
25(17) 1.6875 -1.593

0.117

0.113
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Vaccine Uptake
Logistic regression was originally proposed to assess the impact of a number of factors
on the likelihood that respondents would become vaccinated against HPV during the study. The
model contained four independent variables (HPV knowledge scores, HPV belief scale scores,
group, and insurance). Due to low numbers of respondents actually getting vaccinated (N = 8)
during the study period, logistic regression analysis could not be conducted for this outcome
variable. Vaccine status was verified for all but twelve (6%) participants using a three step
approach (chart audit 42%, state immunization database 39%, and self-report 13%). During chi
square analysis there were equal numbers of participants in both the control (N = 4) and
intervention (N = 4) group who received the HPV vaccine during the study period. For this
reason the outcome variable of interest in the logistic regression model was changed to look at
intentions to accept the HPV vaccine. Intentions to accept the HPV vaccine were determined
based on yes/no response to the question, “If cost were not an issue would you accept the HPV
vaccine for yourself?”.
Using intention to accept the HPV vaccine as the outcome variable, logistic regression
was performed with the same independent variables of HPV knowledge scores, HPV belief scale
scores, group, and insurance. The full model containing all predictors was highly significant, x2
(4, N = 124) = 28.57, p=<0.001, indicating the model could distinguish between respondents
who did and did not indicate intentions toward HPV vaccine. The model as a whole explained
between 21% (Cox and Snell R square) and 28% (Nagelkerke R. Squared) of the variance in
intentions to accept the vaccine, and correctly classified 70% of cases with a sensitivity of 84%
and specificity of 50%. As shown in Table 20, only one of the independent variables made a
unique statistically significant contribution to the model (Total Belief Scale Score) recording an
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odds ratio of 1.142. This indicated that respondents who had increased total belief scale scores
were 1.142 time more likely to have intentions to accept the vaccine than those with lower belief
scale scores.
Table 20.
Logistic regression predicting likelihood of intentions to accept the HPV vaccine
B
S.E.
Wald df
p
Odds
95.0% C.I.
Ratio for Odds Ratio
Lower Upper
HPV Knowledge
-.094
.090 1.081
1 0.298
.91
.763
1.087
Scores
Total Belief Scale
Scores

.133

.033 16.216

1 <0.001

1.142

1.070

1.218

Group

.725

.420

2.986

1

0.084

2.065

.907

4.699

1.222

.644

3.606

1

0.058

3.395

.961

11.991

Insurance Status
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Chapter 5
The purpose of this study was to evaluate the effectiveness of a video based HPV
prevention education intervention compared to written HPV educational material at improving
women’s knowledge, beliefs, and behaviors regarding HPV and HPV prevention. The videobased first account stories of persons diagnosed with HPV and clear messages about prevention
and treatment measures was hypothesized to be a more powerful educational tool for increasing
patients’ knowledge, beliefs, and behaviors regarding HPV and HPV prevention than written
material alone. Based on previous literature, written material alone might not be sufficient to
change health beliefs (Rosen et al., 2010; Waller et al., 2007). In addition, previous literature
supported the use of storytelling for health education of patients as a way to increase patients’
engagement with the material being presented (Comas-Diaz, 2012). By augmenting the written
information with the addition of video-based stories, the learner would be engaged both visually
and auditorily with the information presented in a way that would increase learning about HPV
and HPV prevention.
HPV has been a focus of health care research for many years with a great deal of new
scientific knowledge generated since the release of the HPV vaccine in 2006. However, despite
the growing evidence to support a general lack of knowledge related to HPV among the world's
population, there are still relatively few studies evaluating educational interventions to increase
HPV knowledge. This review showed that only seventeen HPV educational intervention studies
have been conducted in the past 13 years among vaccine eligible adult women. HPV educational
intervention studies are needed to develop an evidence-based model that addresses specific
population needs for HPV information. Additionally, using a strong theoretical framework can
provide guidance for measurement outcomes that might be compared across studies in the future.
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Having uniform, theoretically grounded intervention tools and outcome measures will contribute
to nursing knowledge by generating research that is suitable for comparative effectiveness
studies in the future. Currently, research has not provided evidence to support that a particular
educational intervention is most effective at increasing participants’ knowledge, beliefs, and
behaviors toward HPV prevention. The purpose of this chapter is to discuss the findings of this
study in relation to the current literature on the topic of HPV knowledge, beliefs and behaviors.
Implications for nursing practice will be discussed along with suggestions for future research.
Impact on Knowledge
This study hypothesized that video-based first account stories of persons diagnosed with
HPV and clear messages about prevention and treatment measures would be a more powerful
educational tool for increasing participants’ pap and HPV knowledge than written information
alone. While it was observed that both pap and HPV knowledge significantly increased for both
groups across time, there was no statistically significant difference between the groups based on
type of educational information received. This is similar to Krawczyk et al. (2012) who also
compared written and video delivered HPV information. Krawczyk et al. found that both groups
scored similarly on HPV knowledge at pre-test and post-test. Krawczyk et al. speculated the
reason for this was that the information delivered was identical except for the mode of
information delivery. The researchers suggested that future studies might add music and images
to trigger an emotional response in participants and target the video message to influence target
audiences based on gender, culture, sexual experience, and age. The current study incorporated
some of these elements, specifically music, images, and cultural brokerage through first account
stories of a cervical cancer survivor. While findings from the current study were not statistically
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significant, the video based educational group did have slightly higher knowledge scores than the
written educational group.
Upon enrollment in the study, women’s pap and HPV knowledge levels were low, even
among participants who regularly had contact with health care personnel for pap screening. This
is consistent with the literature suggesting low pap and HPV knowledge exists among women
who have regular contact with health care providers for pap screenings (Cermak et al., 2010; Fry
et al., 2010; Kahn et al., 2005; Waller et al., 2009; Warren, 2010). Findings from this study
support that low pap and HPV knowledge is still a relevant problem today among women who
regularly see health care providers for annual exams. The fact that knowledge deficits persist
despite increasing access to health care providers through the affordable care act is concerning
and speaks to many unmet educational needs that could be influenced by changes in health care
practices.
Reasons for low knowledge despite regular health provider contact is unclear, but may be
due to lack of time in the office for face-to-face education of women (Bayer et al., 2011), or
could reflect a lack of HPV knowledge and self-efficacy among healthcare providers. Further
research into reasons for women’s unmet educational needs regarding HPV is warranted.
Similarly, further research into healthcare providers’ lack of provision of HPV education is also
warranted.
Participants in this study were least knowledgeable regarding the fact transmission of
HPV is via skin to skin contact rather than blood or body fluids. The participants also did not
understand that there were many types of HPV and that the vaccine only protects against some
types of HPV. Knowledge deficits were also related to signs and symptoms of HPV, with many
participants believing HPV was the virus that caused herpes, HIV/AIDS, and many participants
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did not understand the relationship between HPV and abnormal pap smears and cervical cancer.
This is similar to the literature citing the most frequent knowledge deficits among women are
associated with modes of transmission, prevalence, relationship of HPV to cancer, and lack of
knowledge regarding prevention methods (Fry et al., 2010; Kahn et al., 2005; Waller et al., 2009;
Warren, 2010). These discrepancies in accurate HPV knowledge are concerning and suggest a
greater need for accurate health information on HPV. Future educational campaigns should
stress factual HPV information related to the transmission and prevention of HPV.
Additionally, 34% (n = 65) of age eligible women in this study population reported never
having pap testing. The subsequent pap and HPV knowledge scores among this group of study
participants is significantly lower than the women who did attend for pap testing exams. This
reflects similar findings in the HPV literature regarding the connection between regular pap
testing, HPV knowledge, and prevention behaviors (Mills et al., 2011). The lack of participation
in pap screening exams is concerning for this study group as they were noted to have several risk
factors for HPV and cervical cancer (Table 6). Their lack of participation in secondary
prevention of HPV related cancer may be related to their overall lack of pap and HPV knowledge
and is consistent with previous studies showing lack of knowledge is a real barrier to prevention
seeking behaviors (Bynum et al., 2011; Juraskova, Obrien, et al., 2011). Additionally, many
women do not understand the purpose of pap testing is to prevent cervical cancer (Hawkins et al.,
2011; Panagopoulou et al., 2011; Vasconcelos et al., 2011). In fact, women most often report
other reasons (contraception, pelvic pain or symptoms) for attending clinics for pap smear
testing, not related to HPV or cervical cancer screening (Bayer et al., 2011; Bertram &
Magnussen, 2008; Daley et al. 2010; Friedman & Shepeard, 2007; Perrin et al., 2006;
Vasconcelos et al., 2011). Of major importance for future health initiatives is to educate young
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women regarding the age they should start pap testing, the purpose of the pap test, and the
importance of pap testing regardless of vaccine status.
Impact on Health Beliefs
Health Belief Model Constructs
In addition to evaluating women’s knowledge of HPV this study sought to evaluate
changes in women’s health beliefs regarding HPV and HPV prevention. The video based HPV
prevention education intervention was hypothesized to be more effective than written HPV
educational material at improving health belief model constructs (perceived susceptibility,
perceived severity, perceived benefits, perceived barriers, and cues to action) regarding HPV
prevention among women. The supposition was that as perceived susceptibility and severity
increased, participants would perceive greater benefit and fewer barriers to vaccination, leading
to increased uptake of primary prevention vaccination behaviors among the participants in the
study.
Findings showed no significant difference in the effectiveness of the two teaching
approaches on changing participants’ health beliefs. However, there was a significant increase in
the Total Belief Model Scale Scores for both groups over time. Additionally, there was a
significant increase in perceived severity subscale scores for both groups over time, and while
not significant there was a trend of positive changes in each subscale for both groups over time.
In this study, both educational programs were equally effective at changing health beliefs related
to HPV. This is similar to findings by Juraskova, Bari, et al. (2011) who showed significant
changes in perceived severity and perceived benefits following an educational intervention. In
their study, they also noted the subscales of perceived severity and perceived benefits were most
predictive of vaccine behavior. The researchers found that the cues to action subscales were
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more likely than other belief subscales to be a significant predictor of positive attitudes toward
HPV vaccine acceptance. This is consistent with more recent studies of the Health Belief Model,
which suggest the construct of “cues to action” is more predictive of health behaviors than other
constructs in the model (Carpenter, 2010).
Previous HPV studies have utilized the Health Belief Model as a theoretical framework
to guide study interventions. However, most studies have used only part of the model (ie.
perceived susceptibility and severity) rather than the model as a whole, which may make the
study outcomes less predictive (Carpenter, 2010; Harrison et al., 1992). Carpenter (2010)
suggested using the four traditional model constructs (susceptibility, severity, benefits, barriers)
as a whole, and including moderator variables (like “cues to action”). At the time of this study,
there were only two HPV studies utilizing the model as a whole with “cues to action” (Bynum et
al., 2011; Juraskova, Bari, et al., 2011). The current study found that utilizing the model as a
whole was most predictive of vaccine intentions. Future HPV educational intervention studies
should include the model in its entirety for maximum predictive value on outcome variables.
HPV Stigma Beliefs
Lack of HPV knowledge is associated in the literature with increased stigma beliefs
associated with HPV (Bertram & Magnussen, 2008; Daley et al., 2008; Daley et al., 2010;
Lagro-Janssen & Schijf, 2002). Stigma associated with HPV has implications for disease
prevention in the future. Studies have identified stigma associated with HPV as a barrier to
prevention seeking behaviors, partner notification, and social support (Friedman & Shepeard,
2007; Perrin et al., 2006). Addressing the psychosocial stigma attached to HPV is important to
facilitate successful prevention programs.

89

This study hypothesized a video based educational program using a cervical cancer
survivors story would result in greater decreases in HPV related stigma beliefs in women than
written material alone. Findings from the study did not support the hypothesis that the video
based educational program would be more effective than written information alone in changing
women’s HPV stigma beliefs. However, all of the women had higher rates of HPV stigma
beliefs going into the study, which decreased for both groups over time. Therefore, HPV related
stigma beliefs are impacted by factual HPV information, and lower HPV related stigma can
impact HPV prevention seeking behaviors by women (Friedman & Shepeard, 2007; Perrin et al.,
2006).
Prevention
Primary Prevention
HPV vaccination rates are low among women 19-26 years old, with only 20.7% of
women having received at least one dose of HPV (MMWR, February 3, 2012). Several
educational programs among women have sought to change this statistic. While the majority of
studies showed that educational interventions can increase prevention intentions (Crosby et al.,
2008; Fry et al., 2010; Juraskova, Bari et al., 2011; Kahn et al., 2005; Krawczyk et al, 2012;
Kwah et al., 2010; Mock et al., 2007; Papa et al., 2009), one study showed no change in
prevention intentions after receiving the educational intervention (Patel et al., 2012), and another
study showed less participant self-intention to get vaccinated, but higher intentions to get the
vaccine for their children following an educational intervention (Ferris et al., 2007).
This study sought to evaluate the effectiveness of two types of educational program on
vaccine behaviors. However, actual vaccine behaviors could not be evaluated due to too few
participants actually becoming vaccinated during the study period. Subsequently, the
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effectiveness of the two educational programs was evaluated based on ability to predict changes
in attitudes toward vaccination for the participants themselves and their adolescent children.
Findings showed both groups were more willing to accept the vaccine for themselves and their
adolescent children post-intervention, but there was no statistically significant difference
between the two groups on willingness to accept the vaccine for themselves’ or their adolescent
daughters. There was a statistically significant difference in the participants’ willingness to
accept the vaccine for their adolescent sons over time, with the video based education group
being more willing than the control group to accept the vaccine for their adolescent sons at time
2. To determine the cause of this difference the two educational programs were evaluated for
differences in message content. Evaluation showed the video based factual information
regarding who is eligible to receive the HPV vaccine may have been more gender neutral than
the written CDC fact sheet given to the control group. The video message simply provided the
ages for which the vaccine has FDA approval, which includes “all males and females 9-26 years
of age can receive the HPV vaccine”. The CDC hand out is more specific about different age
groups and risk groups who should be vaccinated. The CDC message reads “the vaccine is
recommended for boys and girls ages 11 or 12 years, catch-up ages for boys are from 21-26 and
the CDC recommends the vaccine for gay and bisexual men through age 26, and men and
women through age 26 with an impaired immune system (including people living with
HIV/AIDS)” (CDC, February 23, 2015). Possibly by including specific criteria for gay/bisexual
men in the CDC handout participants were led to believe their son would not need the vaccine if
he were not in this high-risk category. Additionally, it is possible that different age ranges for
recommended and catch-up schedules based on gender led some women in the study to perceive
less need for the vaccine for their adolescent boys when in effect it is equally important to
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vaccinate both genders against HPV in order to eradicate the infection from the population.
Based on findings from this study, content review of parent handouts related to HPV and HPV
vaccine information would be important. Simplified recommendations to include the same age
range for both genders irrespective of other risk factors with long-term eradication of HPV
infection among the general population as a goal might be more effective in swaying parent
decisions to vaccinate adolescent children.
Secondary Prevention
There was a fairly large proportion of 18-26 years old women in this study who had not
yet had a pap smear screening test (34%). This rate is higher than the national average of 22%
for women (aged 18-65 years) who have not undergone pap testing (NCI, 2005). It is difficult to
make a direct comparison of this number however, because the sample for this study is much
smaller and the age ranges are not equal.
However, among those who had never had pap smear screening, 46% were above the age
of 21 years when regular pap screening is advised. It is not clear why these women were not
getting regular pap smear screening, but lack of knowledge regarding the benefits of regular pap
testing may be a factor. It was observed that women naïve to pap testing had significantly lower
pap knowledge scores at time 1 (M = 3.31, SD 2.09) than women who had pap testing prior to
the study (M = 4.91, SD 1.16) t (73.65) = -5.45, p = .000 (two-tailed). Even though non-pap
testing women had their knowledge increased over time (M = 4.5, SD 1.17), it was still
significantly lower than the pap testing group of women (M = 5.16, SD .81) at time 2, t (89.41) =
-3.68, p = .000 (two-tailed). Based on this data it is impossible to say whether age eligible
screening participant lack of participation in pap screening is attributable to lack of knowledge
regarding the need for screening or rather conversely their lack of knowledge is a result of no
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exposure to pap screening. What can be inferred is a large portion of age eligible women in this
study are not getting the recommended screened for HPV and cervical cancer, and according to
responses on age of sexual debut and lifetime number of sexual partners they are at high-risk for
HPV transmission. The findings in this study highlight a need for additional education among
young women regarding the value of regular pap screening exams.
Significance of the Study
Contribution to Nursing Knowledge and Practice
Understanding women’s HPV knowledge, beliefs and behaviors has implications for
nursing practice because the current national vaccine uptake rate among adult women is low at
20%. Studies among women have shown a connection between HPV knowledge and beliefs and
vaccine uptake. However, there are discrepancies in the literature regarding the most effective
information and educational delivery format to meet this need. This study sought to compare the
effectiveness of two type of information delivery on changing women’s HPV knowledge, beliefs,
and behaviors. Several implications can be drawn from the study to inform practice.
First, nurses are often the first point of contact patients have for health care information,
and according to respondents in this study health care providers are the most trusted source of
health information. However, this study demonstrated that women are not receiving adequate
pap and HPV education despite having regular contact with health care providers for pap testing.
It is unclear why they aren’t receiving education, but their lack of knowledge does have a direct
impact on their willingness to accept the HPV vaccine for themselves and their adolescent
children. Both groups in this study were more willing to accept the vaccine for themselves and
their adolescent children post-intervention. Thus, increasing women’s knowledge of HPV and
the HPV vaccine could in time have a positive influence on HPV vaccine rates. Additionally, by
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providing gender neutral HPV educational information nurses may see greater willingness to
accept HPV vaccination for adolescent boys.
Nursing can also play an important role in women’s knowledge regarding pap screening
exams. Many participants in this study who were age eligible were not yet having recommended
pap screening tests. Nursing can influence this by reminding young women at every opportunity
about recommended preventive health testing that should occur. Also observed in this study is
that even among women who were getting regular pap testing their pap and HPV knowledge was
low. Thus, it is important that nurses not assume that women attending regularly for pap testing
already know all about the test, HPV, or other sexual health issues. Nurses need to treat every
health care visit as an opportunity to broaden a patient’s knowledge of health topics.
Beyond understanding the importance of health prevention behaviors, nurses also play a
role in removing barriers to health care. In this study, the most common barriers to vaccination
cited by participants were cost and fear of vaccines. Nurses can play a critical role in removing
these two barriers by helping patients locate local clinics where the vaccine is available for
low/no cost. Additionally, myths are pervasive in the public and through social media regarding
the HPV vaccine that can falsely elevate peoples’ fear of the vaccine. As such, dissemination of
factual HPV information in places commonly viewed by the general public would be important
for nurses to combat fears perpetuated by inaccurate information. Nurses should consider
dissemination of HPV vaccination facts and dispelling myths in popular and accessible media
including magazines and online social media forums. In this study, participants attending family
planning clinics were more often getting the HPV information than women from the general
population without access to regular health care. Thus, nurses need to step outside of their
traditional work environments to reach women with minimal exposure to the health care system.
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In this study, women had many unmet pap and HPV knowledge needs, which provide
evidence of a major gap in nursing practice. Additional research among nursing/health care
personnel is needed to determine their knowledge of HPV and their self-efficacy to educate
patients regarding prevention.
Potential Impact on Health and Quality of Life
HPV is associated with significant morbidity and mortality. HPV morbidity is related to
the chronic potential recurrence of genital warts, the psychological experience of stigma related
to HPV diagnosis, and fear of cancer associated with HPV related cervical dysplasia. While
HPV mortality has decreased among developed countries utilizing secondary prevention (pap
testing), lives saved could be greater with increased awareness and acceptance of HPV primary
prevention (vaccination). Currently, there is an underutilization of available HPV primary
prevention services. This study supports both HPV primary and secondary prevention services
are not being fully utilized by age eligible women, and many in the study were high-risk for HPV
and its associated morbidity.
Participants in this study had several risk factors for HPV (young age of sexual debut,
multiple partners, lack of condom use, etc.) and approximately 10% of participants in this study
reported a previous diagnosis of HPV. This has significant implications for health and quality of
life for study participants as those diagnosed with HPV will have to undergo expensive and often
physically and psychologically painful diagnostic and treatment procedures to prevent later
development of cervical cancer. Any effort we can make as a health care community to prevent
morbidity associated with HPV infection is worthwhile.
Despite many participants having insurance coverage in this study, the most cited barriers
to utilization of prevention services in this study was cost, availability, and fear of vaccines.
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This finding suggest there may be social and health policy implications needing addressed in
order to remove barriers to prevention services for adult women. Health policy legislation that
could expand HPV vaccine availability to private physician offices, pharmacies, and other
potential sources of access to adult women would be important to consider.
Vaccine Availability and Uptake
Despite being age eligible for the HPV vaccine, none of the study participants had yet
been vaccinated upon enrollment in this study. A small number became vaccinated during the
study (n = 8). Respondents reported several potential reasons for lack of vaccination.
Lack of availability of the vaccine for adult women is concerning. Fourteen percent of
respondents at time 1 versus 10% at time 2 reported non-availability of the vaccine as a barrier to
getting vaccinated. In this study, participants’ intentions toward accepting the vaccine increased
after learning more about HPV and the HPV vaccine, however, their behaviors toward
vaccination during the study protocol indicated that while they were more inclined to accept the
vaccine, few actually got vaccinated. Perhaps lack of vaccine availability is one reason for this
finding. This has implication for future policy that might mandate greater availability of the
vaccine for adult populations. First, policies might suggest expanded federal VFC funding for
adult doses of the vaccine for those who are under or uninsured. Additionally, policies could be
implemented at the state and national level to require access for all insured patients to adult
vaccines health departments around the nation. Finally, health policy could be implemented to
require the HPV vaccine for seventh grade entry along with other adolescent vaccines. This type
of policy would eventually solve the problem of children reaching adulthood without receiving
the HPV vaccine.
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While the vaccine is available in every state and county in the nation, the vaccine may
only be available at county health departments or clinics who subscribe to the Vaccines for
Children funds. Additionally, these programs stock primarily for adolescent populations and
may not have a large supply of private pay stock for adults due to the expense of maintaining a
private vaccine supple. Many private physician offices opt not to stock vaccines due to the
expense of maintaining the supply in low volume clinic settings.
Additionally, even though 84% of the population reported having insurance coverage,
nearly 41% of respondents at time one and 34% at time 2 noted cost was a barrier to getting
vaccinated. This finding reflects that while many more young people are being insured through
the Affordable Care Act, there may be gaps in insurance coverage for vaccinations. Many
women in this age group may fall through the cracks for age eligibility for government
sponsored Vaccine Programs, which could impact women’s ability to become vaccinated. While
this study promoted pharmaceutical company charity programs for uninsured women, not all
clinics were willing to subscribe to these program as they require extra paperwork and up front
expense prior to reimbursement. For these reasons most clinics contacted during the study chose
to refer patients to local health departments for vaccine services.
Another reason for lack of vaccine uptake may have been respondents’ lack of perceived
need for the vaccine. Based on comments by participants their lack of perceived need stemmed
from many factors. Some felt that because they were currently monogamous with a male partner
or lesbian, the vaccine was not needed. Additionally, many felt that because they were at the end
of the age bracket for suggested vaccination, they were too late to begin HPV vaccination. A
few participants reported already being diagnosed with HPV as a reason not to get the vaccine.
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Many of these statements reflect a lack of understanding regarding HPV and HPV
vaccination. Recommendations for vaccination are not made based on monogamy or lesbian
sexual orientation, thus any woman up to the age of 26 years should consider getting the HPV
vaccine. Additionally, even if a woman is already 26 years old and will turn 27 before finishing
the HPV vaccine series, she can still start the vaccine series. The age cut off of 26 years is made
based on what we know about HPV pathophysiology and epidemiology. Based on
pathophysiology and epidemiology of HPV it is felt the vaccine is most cost effective when
given at younger ages. There are no added safety concerns if a woman should finish her vaccine
series after she turns 27 years old. Finally, participants’ feeling they could not be vaccinated
because they were already diagnosed with HPV is a misperception common among many people.
In actuality previous diagnosis of any HPV strain does not confer immunity towards additional
HPV strains (Wheeler, 2007). Nor does clearing the virus confer immunity against reinfection
with the same HPV type in the future. Thus, all women regardless of previous diagnosis with
HPV are encouraged to become vaccinated against available HPV strains in the vaccine.
Overall, these statements reflect the lingering lack of knowledge many people have regarding
HPV types, transmission, and the vaccine in general.
Finally, many respondents had an inherent fear of risks of vaccines as a reason for
avoiding HPV vaccine uptake. This is troubling given there is a large body of scientific evidence
suggesting the benefits of vaccines far outweigh the risks of vaccination. In particular, the HPV
vaccine has an excellent safety profile with the most common side effects being pain and
irritation at the injection site (Wheeler, 2007; FDA, 2015).
Respondents’ concern for HPV vaccine safety suggests an ongoing need for continued
education on the topic of HPV vaccine safety. Future educational programs must include factual

98

information regarding HPV vaccine safety as a way to decrease perceived barriers to vaccine
uptake among women. Furthermore, nurses should be trained in delivering HPV information to
young women and in promoting HPV vaccination.
Suggestions for Future Research
The current study represented a prospective quasi-experimental, pre-test/post-test design
with delayed intervention treatment administered to the control group at study completion. The
study was done because there was a lack in the current HPV literature reflecting effective HPV
educational material and approaches for young women. Prior to this study there had only been
two video delivered studies among women. One of which measured knowledge and the other
assessed behavior outcomes following the intervention. This study was designed to evaluate the
effectiveness of a video based educational program on women’s knowledge and behaviors in
comparison to the standard of care of written material alone.
This study found there was no difference in the effectiveness of the two types of
educational material on HPV knowledge, however, both groups’ HPV knowledge and attitudes
scores improved following the different types of interventions. Also, the video-based education
was significantly more effective at increasing women’s willingness to accept the HPV vaccine
for their adolescent sons. Therefore, future studies might build upon this by studying the video
based educational program among a larger sample of mothers of adolescent sons to see if the
same result is obtained and whether the video-based education might influence actual vaccine
uptake among adolescent boys.
This study also found that while women are attending for pap screening they still have
low pap and HPV knowledge scores suggesting they are not having all their educational needs
met at these health care visits. Reasons for lack of educational information among women who
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have contact with health care providers is unclear, but future research may uncover factors
influencing the provision of HPV education to women in the clinic setting. Additionally, future
research should explore nurses/health care providers’ knowledge of HPV and their self-efficacy
to educate patients on the topic. Possibly nurses and health care providers in general have unmet
HPV and HPV vaccine knowledge needs.
Limitations
The majority of this sample was Caucasian with little ethnic or racial diversity and most
respondents were living in rural Appalachia. Therefore, inferences cannot be made about
women from other ethnicities, races, or geographic locations. Another limitation of this study
related to recruitment procedures. Issues arose during face-to-face recruitment in clinic causing
the researcher to amend the IRB protocol to expand recruitment to the workforce, internet, and
university student email. Self-selection to an on-line survey poses challenges for verification of
participant inclusion/exclusion criteria. However, of the 194 participants recruited in the study,
only 12 were completely unverifiable for meeting inclusion criteria. The additional 182 were
verifiable for female gender, age, and vaccine status. Also because participants self-selected for
this study they may have some biases toward the topic, which would make their responses less
representative of the population as a whole.
Another limitation was the inclusion/exclusion criteria for this study were too strict.
Several women in the clinic were age eligible for the study and wanted to participate, but had
already had at least one HPV shot which excluded them from the study. After moving the
recruitment to the university student email more non-vaccinated women were found for the
study. Additional studies among university students evaluating why they are not as likely to
have gotten the vaccine would be important. Perhaps there is a need for greater awareness and

100

access to health care services like vaccination among this age group of women in the community
and on campus.
Many HPV studies have assessed the impact of HPV knowledge on increasing HPV
vaccine intentions. Few studies have assessed actual vaccine uptake behaviors. This study
included assessment of actual vaccine uptake. However, few participants (control n = 4,
intervention n= 4) received the HPV vaccine during the study. The low numbers of actual
vaccine uptake in this study prevented analysis of the impact HPV education might have on
vaccine uptake. Therefore, a limitation of this study was that conclusions could only be drawn
regarding the impact of HPV education on intentions toward HPV vaccination rather than actual
vaccine behaviors, which would have been preferred. It is not completely clear why so few
participants became vaccinated during this study, but perhaps identified barriers of cost, access,
and fear of shots were factors. Future studies should be designed to address these barriers in
order to assess the impact education might have on actual vaccine behaviors.
Finally, a limitation of this study was that the control group in this study might have
actually received more education than is typical of standard of care. While the researcher felt
written information alone was probably more typical of standard of care, it may be that no
education of any type is more typical of the standard of care. This finding is based on the
evidence in this study showing that women who regularly attended clinics for pap test still have
low levels of baseline knowledge.
Conclusions
In conclusion, there is a need for additional HPV research focusing on theoretically
grounded educational interventions among differing populations at risk for HPV. In particular
there is a need for additional research to determine why women who have regular contact with
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health care providers are still having unmet HPV knowledge needs. A study among health care
personnel related to this topic might provide valuable insight into this problem. Additionally,
more research needs to be conducted regarding the importance of gender bias in HPV vaccine
recommendations. This study indicates there was a statistically significant increase in women’s
willingness to vaccinate adolescent sons following the video based educational program.
Replication of this study among parents of adolescent children would be important as a way of
informing our knowledge regarding adaptations needed on future CDC HPV literature.
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Appendix A: Information cover letter for participants
Dear Participant,
This letter is a request for you to take part in a research project to assess your knowledge, beliefs,
and behaviors associated with HPV and HPV vaccination. This project is being conducted by
Crystal Sheaves, a doctoral student at West Virginia University School of Nursing. Crystal
Sheaves will administer this research project under the supervision of her Dissertation Chair, Dr.
Ilana Chertok. Your participation in this project is greatly appreciated and will take
approximately 20 minutes (to fill out a short survey and receive HPV educational material).
Your involvement in this project will be confidential, and no identifying information will be
collected on the survey. All data will be reported in aggregate. You must be 18 -26 years old,
have never received a HPV shot, and non-pregnant to participate. Your participation is
completely voluntary, and you may discontinue at any time. Your visit today at the doctor’s
office will not be affected in any way if you choose not to participate in this study. West
Virginia University's Institutional Review Board acknowledgement of this project is on file.
I hope that you will participate in this research project, as it could be beneficial in understanding
the strength of the HPV knowledge, beliefs, and behaviors of women in West Virginia. Thank
you very much for your time. Should you have any questions about this letter or the research
project, please feel free to contact Crystal Sheaves at (304) 573-6963 or by e-mail at
csheaves@hsc.wvu.edu. In addition, if you have questions or concerns regarding this study you
may contact the West Virginia University Office of Research Compliance at 304-293-7073 ext.
3.
For more information on HPV, please visit the CDC website at: http://www.cdc.gov/hpv/
You are also encouraged to discuss any questions or concerns you may have about HPV with
your medical provider. In addition, a list of counseling services in your area is attached, if you
should feel the need to discuss any concerns that arose after taking the survey.
Thank you for your time and help with this project.
Sincerely,

Crystal Sheaves
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Appendix B: Pre-test HPV knowledge, beliefs, and behaviors questionnaire
Survey: _______

HPV Knowledge, Beliefs, and Behaviors Questionnaire
Please, read each question and put a check (√) beside your answer. If you do not want
to answer a question, you can leave it blank. Only mark one response for each
question, unless you are asked to “check all that apply.”
Questions about You
1.

How old are you? ______

2.

What is your race?
White
African American or Black
Hispanic or Latino
Asian
American Indian or Alaska Native
Native Hawaiian or Other Pacific Islander
Other race (Please specify)______________________

3.

What best describes your sexual orientation?
Heterosexual
Gay/Lesbian
Bisexual
Unsure

4.

What is your current relationship status?
Single
Married
Living with Partner (i.e., boyfriend/girlfriend)
Divorced/Separated
Other (Please Specify)_______________________________

5.

What is your highest level of education?
Some high school
High school graduate or GED equivalent
Associates Degree or Some college
Bachelor’s degree or Associate’s degree
Graduate/professional degree (i.e., Masters, PhD, MD)

6.

How do you pay for your health care appointments? (CHECK ONLY ONE)
Private insurance
Medicaid
Clinic program (BCCSP, Family Planning, Sliding Scale, etc.)
Out-of-Pocket (Private Pay)
None
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7.

Do you smoke?
Yes
No

Questions about Your Sexual History
8.

Have you ever had sexual intercourse? (Sexual intercourse includes vaginal, oral,
or anal sex.)
Yes
No

9.

How old were you when you had sexual intercourse for the first time? ________

10.
During your lifetime, with how many people have you had sexual intercourse
with? ________
11.

The last time you had sexual intercourse, did you or your partner use a
condom?
Yes
No
Don’t Know/Not Sure

12.

In general, do you use condoms to (CHECK ALL THAT APPLY):
Prevent pregnancy
Prevent sexually transmitted infections (STIs) (also called STDs)
Prevent HIV infection (the virus that causes AIDS)
other reason (Please specify)________________________________________

13.
IUD)

Do you use hormonal contraceptives? (birth control pills, depo shot, or
Yes
No

14.

How many times have you been pregnant?
0
1
2
3
4
5 or more

15.

How many live births have you had?
0
1
2
3
4
5 or more
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16.

Have you ever had a Pap smear also known as a Pap test?
Yes
No
Don’t Know/Not Sure

17.

How long has it been since you had your last Pap smear?
Less than 12 months ago
2 years ago
3 years ago
4 years ago
5 years ago
5 or more years ago
Don’t Know/Not Sure

18.

Have you ever been told by a health care provider that your Pap smear result is
“abnormal”?
Yes
No
Don’t Know/Not Sure

19.

Have you ever been told by a health care provider that you had a sexually
transmitted infection or disease also called an STD or STI?
Yes
No
Don’t Know/Not Sure

20.

Have you ever been told by a health care provider that you have HPV?
Yes
No
Don’t Know/Not Sure

21.

If Yes, did your health care provider tell you that you had a high-risk type of
HPV?
Yes
No
Don’t Know/Not Sure

22.

If Yes, did your health care provider tell you that you had a low-risk type of HPV?
Yes
No
Don’t Know/Not Sure
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Questions about Your Sexual Health
23.

Please tell us how much you agree or disagree with the statements (from
“strongly disagree” to “strongly agree”).
Strongly
Disagree

Disagree

Agree

Strongly
Agree

a. It is difficult for me to find effective solutions for the sexual
health problems that come my way.

b. I’m generally able to accomplish my goals with regard to
my sexual health needs.

c. I succeed in things I do to improve my sexual health.
d. I am directly responsible for my sexual health.
Pap Smear Knowledge
24.

Please, respond to the following statements about HPV as TRUE, FALSE, or
DON’T KNOW.
(If you don’t know, check “DON’T KNOW.”)

True

False

a. A Pap smear is a test to find out if a woman is pregnant.
b. All women should be getting Pap smears by the time they are 21
years old.

c. A Pap smear checks for changes in the cells of a woman’s uterus,
also called the womb.

d. A Pap smear checks for changes in the cells of a woman’s cervix.
e. Getting regular Pap smears is the best thing a woman can do to
prevent cervical cancer.

f. If a woman has a Pap smear result that is not normal that usually
means that she has cancer.

HPV Knowledge and Awareness
25.

Have you ever heard of HPV? (HPV stands for human papillomavirus.)
Yes
No

26.

Have you ever heard of the HPV vaccine? (also called the HPV shot or
GARDASIL.)
Yes
No

Don’t
Know
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27.

a.

Please, respond to the following statements about HPV as TRUE, FALSE, or
DON’T KNOW.
(If you don’t know, check “DON’T KNOW.”)
True
False
Don’t Know

HPV can cause HIV/AIDS.

b. You can always tell when someone has HPV.
c.

HPV can cause abnormal Pap smears/ Pap tests.

d.

Only women get HPV.

e.

HPV can cause herpes.

g.

HPV can cause genital warts.

h.

You can have HPV without knowing it

i.

HPV is a sexually transmitted infection (STI) or STD.

j.

HPV can cause cervical cancer.

k.

The HPV vaccine protects against all HPV infections?

l.

Condoms are not 100% effective at preventing HPV?

m. HPV is spread by skin to skin contact?

HPV Vaccine Acceptability
28.

If cost was not an issue, would you get the vaccine to prevent HPV
infection?
Yes
No
Don’t Know/Not Sure

29.
What are the barriers or reasons for not getting the HPV vaccine? (CHECK
ALL THAT
APPLY)
Cost
Not available
Risks with shots
No need
Other: __________________
30.

Do you know where to go to get the HPV vaccine?
Yes
No

31.

If you have an 11-12 year-old daughter (or became the parent of one in the future),
would you have her vaccinated against HPV?
Yes
No
Don’t Know/Not Sure
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32.

If you have an 11-12 year-old son (or became the parent of one in the
future), would you have him vaccinated against HPV?
Yes
No
Don’t Know/Not Sure

Attitudes, Beliefs, and Perceptions about HPV and HPV Vaccine
33.

a.
b.
c.
d.

This section asks about your beliefs and perceptions about HPV and the HPV
vaccine. Please tell us whether you agree or disagree with the following
statements (from “strongly disagree” to “strongly agree”).
Strongly
Strongly
Disagree Disagree
Agree
Agree
Most people think that people with HPV should
be ashamed of themselves
Most people think that people with HPV are to
blame for their problem
Most people think that people with HPV are a
danger to others
Only people who are sexually promiscuous get
HPV
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Strongly
Disagree

Disagree

Agree

Strongly
Agree

Agree

Strongly
Agree

e. It is extremely likely that I will get HPV in my
lifetime.

f. My current behaviors put me at risk for HPV.
g. HPV is a very common infection
h. My risk of getting HPV is higher than most
people’s risk

Strongly
Disagree

i.

Disagree

HPV is a serious infection.

j. Cervical cancer is a serious disease.
k. HPV can be life-threatening
l. HPV is very likely to cause cervical cancer

Strongly
Disagree

Disagree

Agree

Strongly
Agree

Strongly
Disagree

Disagree

Agree

Strongly
Agree

m. I cannot afford to get the HPV vaccine.
n. I would not get the HPV vaccine because I am
afraid of needles.

o. I do not think vaccines work.
p. I have concerns about whether the HPV vaccine
is safe.
q. I have concerns about whether the HPV vaccine
is effective.
r. I have concerns about possible side effects of the
HPV vaccine.

s. Getting the HPV vaccine could save my life.
t. Getting the HPV vaccine could protect me from
getting certain types of HPV.

u. Getting the HPV vaccine will reduce the chance
of me getting cervical cancer in the future.
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Strongly
Disagree

Disagree

Agree

Strongly
Agree

v. Knowing that HPV affects people like me would
encourage me to get the HPV vaccine.
w. Knowing more about HPV would encourage me
to get the HPV vaccine.
x. If my doctor recommended that I get the HPV
vaccine then I would get it.
y. If my mother approved of the HPV vaccine then I
would approve of it also.
z. If my grandmother approved of the HPV vaccine
then I would approve of it also.
aa. If my friends approved of the HPV vaccine then I
would approve of it also.

Questions about Your Health Information Sources
34.

Have you ever attended an HPV-related event?
No
Yes

35.
Have you ever seen the “Tell Someone”, “One Less”, or other television
commercials about
the HPV vaccine also called the HPV shot or GARDASIL?
Yes
No
36.

If you wanted information on HPV, how would you like to receive this information?
(CHECK ALL THAT APPLY)
Health care provider
Pamphlets
Internet websites
TV
Family
Friends
School Health Center
Other (Please specify)_______________________________________________

37.
Which source of health information do you use the most? (CHECK ALL THAT
APPLY)
Health care provider
Pamphlets
Internet websites
TV
Family
Friends
School Health Center
Other (Please specify)________________________________________________
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38.
Which ONE source of health information do you trust the most? (CHECK ALL
THAT APPLY)
Health care provider
Pamphlets
Internet websites
TV
Family
Friends
School Health Center
Other (Please specify)
__________________________________________________

Thank you for filling out the survey!
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Appendix C: Genital HPV infection – CDC fact sheet
What is HPV?
HPV is the most common sexually transmitted infection (STI). HPV is a different virus than HIV and HSV (herpes). HPV is so
common that nearly all sexually active men and women get it at some point in their lives. There are many different types of
HPV. Some types can cause health problems including genital warts and cancers. But there are vaccines that can stop these
health problems from happening.
How is HPV spread?
You can get HPV by having oral, vaginal, or anal sex with someone who has the virus. It is most commonly spread during
vaginal or anal sex. HPV can be passed even when an infected person has no signs or symptoms.
Anyone who is sexually active can get HPV, even if you have had sex with only one person. You also can develop symptoms
years after you have sex with someone who is infected making it hard to know when you first became infected.
Does HPV cause health problems?
In most cases, HPV goes away on its own and does not cause any health problems. But when HPV does not go away, it can
cause health problems like genital warts and cancer.
Genital warts usually appear as a small bump or group of bumps in the genital area. They can be small or large, raised or
flat, or shaped like a cauliflower. A healthcare provider can usually diagnose warts by looking at the genital area.
Does HPV cause cancer?
HPV can cause cervical and other cancers including cancer of the vulva, vagina, penis, or anus. It can also cause cancer in
the back of the throat, including the base of the tongue and tonsils (called oropharyngeal cancer).
Cancer often takes years, even decades, to develop after a person gets HPV. The types of HPV that can cause genital warts
are not the same as the types of HPV that can cause cancers.
There is no way to know which people who have HPV will develop cancer or other health problems. People with weak
immune systems may be less able to fight off HPV and more likely to develop health problems from it, this includes people
with HIV/AIDS.
How can I avoid HPV and the health problems it can cause?
You can do several things to lower your chances of getting HPV.
Get vaccinated. HPV vaccines are safe and effective. They can protect males and females against diseases (including
cancers) caused by HPV when given in the recommended age groups (see “Who should get vaccinated?” below).
HPV vaccines are given in three shots over six months; it is important to get all three doses.
Get screened for cervical cancer. Routine screening for women aged 21 to 65 years old can prevent cervical cancer.
If you are sexually active
•

Use latex condoms the right way every time you have sex. This can lower your chances of getting HPV. But HPV can
infect areas that are not covered by a condom - so condoms may not give full protection against getting HPV
• Be in a mutually monogamous relationship – or have sex only with someone who only has sex with you.
Who should get vaccinated?
All boys and girls ages 11 or 12 years should get vaccinated.
Catch-up vaccines are recommended for males through age 21 and for females through age 26, if they did not get
vaccinated when they were younger.
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The vaccine is also recommended for gay and bisexual men (or any man who has sex with a man) through age 26. It is also
recommended for men and women with compromised immune systems (including people living with HIV/AIDS) through age 26, if
they did not get fully vaccinated when they were younger.
How do I know if I have HPV?
There is no test to find out a person’s “HPV status.” Also, there is no approved HPV test
to find HPV in the mouth or throat.
There are HPV tests that can be used to screen for cervical cancer. These tests are
recommended for screening only in women aged 30 years and older. They are not
recommended to screen men, adolescents, or women under the age of 30 years.
Most people with HPV do not know they are infected and never develop symptoms or
health problems from it. Some people find out they have HPV when they get genital
warts. Women may find out they have HPV when they get an abnormal Pap test result
(during cervical cancer screening). Others may only find out once they’ve developed
more serious problems from HPV, such as cancers.
How common is HPV and the health problems caused by HPV?
HPV (the virus): About 79 million Americans are currently infected with HPV. About 14
million people become newly infected each year. HPV is so common that most sexuallyactive men and women will get at least one type of HPV at some point in their lives.
Health problems related to HPV include genital warts and cervical cancer.
Genital warts: About 360,000 people in the United States get genital warts each year.
Cervical cancer: More than 11,000 women in the United States get cervical cancer each
year.
There are other conditions and cancers caused by HPV that occur in persons living in the
United States.
I’m pregnant. Will having HPV affect my pregnancy?
If you are pregnant and have HPV, you can get genital warts or develop abnormal cell
changes on your cervix. Abnormal cell changes can be found with routine cervical cancer
screening. You should get routine cervical cancer screening even when you are pregnant.

Where can I get more
information?
STD information
http://www.cdc.gov/std/
HPV Information
http://www.cdc.gov/hpv/
HPV Vaccination
http://www.cdc.gov/vaccines/
vpd-vac/hpv/
Cancer Information
http://www.cdc.gov/cancer/
Cervical Cancer Screening
http://www.cdc.gov/cancer/
cervical/basic_info/screening.
htm
CDC’s National Breast and
Cervical Cancer Early Detection
Program
http://www.cdc.gov/cancer/
nbccedp/
CDC-INFO Contact Center
1-800-CDC-INFO
(1-800-232-4636)
Contact www.cdc.gov/info
CDC National Prevention
Information Network (NPIN)
https://npin.cdc.gov/disease/stds

Can I be treated for HPV or health problems caused by HPV?

P.O. Box 6003

There is no treatment for the virus itself. However, there are treatments for the health
problems that HPV can cause:

Rockville, MD 20849-6003
E-mail: npin-info@cdc.gov

1.

Genital warts can be treated by you or your physician. If left untreated, genital
warts may go away, stay the same, or grow in size or number.

2.

Cervical precancer can be treated. Women who get routine Pap tests and follow
up as needed can identify problems before cancer develops. Prevention is
always better than treatment. For more information visit www.cancer.org.

National HPV and Cervical Cancer
Prevention Resource Center
American Sexual Health Association
(ASHA)
http://www.ashasexualhealth.org/
stdsstis/hpv/

3.

Other HPV-related cancers are also more treatable when diagnosed and treated
early. For more information visit www.cancer.org.

P.O. Box 13827
Research Triangle Park,
NC 27709-3827
1-800-783-9877
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Appendix D: Post-test HPV knowledge, beliefs, behaviors questionnaire

I

Survey: _______

HPV Knowledge, Beliefs, and Behaviors Questionnaire
Please, read each question and put a check (√) beside your answer. If you do not want
to answer a question, you can leave it blank. Only mark one response for each
question, unless you are asked to “check all that apply.”
Pap Smear Knowledge
24.

Please, respond to the following statements about HPV as TRUE, FALSE, or
DON’T KNOW.
(If you don’t know, check “DON’T KNOW.”)

True

False

g. A Pap smear is a test to find out if a woman is pregnant.
h. All women should be getting Pap smears by the time they are 21
years old.

i.

A Pap smear checks for changes in the cells of a woman’s uterus,
also called the womb.

j.

A Pap smear checks for changes in the cells of a woman’s cervix.

k. Getting regular Pap smears is the best thing a woman can do to
prevent cervical cancer.

l.

If a woman has a Pap smear result that is not normal that usually
means that she has cancer.

HPV Knowledge and Awareness
25.

Have you ever heard of HPV? (HPV stands for human papillomavirus.)
Yes
No

26.

Have you ever heard of the HPV vaccine? (also called the HPV shot or
GARDASIL.)
Yes
No
Please, respond to the following statements about HPV as TRUE, FALSE, or
DON’T KNOW.
(If you don’t know, check “DON’T KNOW.”)

27.

Don’t
Know
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True
a.

HPV can cause HIV/AIDS.

c.

You can always tell when someone has HPV.

c.

HPV can cause abnormal Pap smears/ Pap tests.

d.

Only women get HPV.

e.

HPV can cause herpes.

g.

HPV can cause genital warts.

h.

You can have HPV without knowing it

i.

HPV is a sexually transmitted infection (STI) or STD.

j.

HPV can cause cervical cancer.

k.

The HPV vaccine protects against all HPV infections?

l.

Condoms are not 100% effective at preventing HPV?

False

Don’t Know

m. HPV is spread by skin to skin contact?

HPV Vaccine Acceptability
28.

If cost was not an issue, would you get the vaccine to prevent HPV
infection?
Yes
No
Don’t Know/Not Sure

29.
What are the barriers or reasons for not getting the HPV vaccine? (CHECK
ALL THAT
APPLY)
Cost
Not available
Risks with shots
No need
Other: __________________
30.

Do you know where to go to get the HPV vaccine?
Yes
No

31.

If you have an 11-12 year-old daughter (or became the parent of one in the future),
would you have her vaccinated against HPV?
Yes
No
Don’t Know/Not Sure

32.

If you have an 11-12 year-old son (or became the parent of one in the
future), would you have him vaccinated against HPV?
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Yes
No
Don’t Know/Not Sure

Attitudes, Beliefs, and Perceptions about HPV and HPV Vaccine
33.

This section asks about your beliefs and perceptions about HPV and the HPV
vaccine. Please tell us whether you agree or disagree with the following
statements (from “strongly disagree” to “strongly agree”).
Strongly
Strongly
Disagree Disagree
Agree
Agree
bb. Most people think that people with HPV should be
ashamed of themselves
cc. Most people think that people with HPV are to blame
for their problem
dd. Most people think that people with HPV are a danger
to others

ee. Only people who are sexually promiscuous get HPV

Strongly
Disagree

Disagree

Agree

Strongly
Agree

Strongly
Disagree

Disagree

Agree

Strongly
Agree

Agree

Strongly
Agree

ff. It is extremely likely that I will get HPV in my
lifetime.

gg. My current behaviors put me at risk for HPV.
hh. HPV is a very common infection
ii. My risk of getting HPV is higher than most people’s
risk

jj. HPV is a serious infection.
kk. Cervical cancer is a serious disease.
ll. HPV can be life-threatening
mm. HPV is very likely to cause cervical cancer

Strongly
Disagree

Disagree
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nn. I cannot afford to get the HPV vaccine.
oo. I would not get the HPV vaccine because I am
afraid of needles.

pp. I do not think vaccines work.
qq. I have concerns about whether the HPV vaccine is
safe.
rr. I have concerns about whether the HPV vaccine is
effective.
ss. I have concerns about possible side effects of the
HPV vaccine.

Strongly
Disagree

Disagree

Agree

Strongly
Agree

Strongly
Disagree

Disagree

Agree

Strongly
Agree

tt. Getting the HPV vaccine could save my life.
uu. Getting the HPV vaccine could protect me from
getting certain types of HPV.

vv. Getting the HPV vaccine will reduce the chance
of me getting cervical cancer in the future.

ww.

Knowing that HPV affects people like me
would encourage me to get the HPV vaccine.
xx. Knowing more about HPV would encourage me
to get the HPV vaccine.
yy. If my doctor recommended that I get the HPV
vaccine then I would get it.
zz. If my mother approved of the HPV vaccine then I
would approve of it also.
aaa. If my grandmother approved of the HPV
vaccine then I would approve of it also.
bbb. If my friends approved of the HPV vaccine
then I would approve of it also.

Thank you for filling out the survey!
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Appendix E:
(Permission Dr. Bynum)

From: Shalanda Bynum
[Shalanda.Bynum@usuhs.mil]
Sent: Tuesday, January 31,
2012 8:35 AM
To: Sheaves, Crystal
Subject: Re: FW: Dr.
Shalanda Bynum
Hi Crystal,

Please find attached the 52item survey as well as three
publications with published
reliability statistics for
each construct and my
student sample. Please let
me know if I can be of
further help.

Best! sb
-------------------------------------------------------------------------Shalanda A. Bynum, PhD, MPH
Assistant Professor of
Social & BehavioralSciences
Department of Preventive
Medicine & Biometrics
E. Edward Hebert School of
Medicine
Uniformed Services
University of the
HealthSciences
4301 Jones Bridge Road,
Bethesda, MD 20814
Tel : (301) 295-1585; Fax:
(301) 295-1933
E-mail:
shalanda.bynum@usuhs.mi

